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Preface 
Burden of disease analysis is a way of simultaneously counting and comparing the fatal and 
non-fatal impacts of different diseases and injuries. It uses information from multiple data 
sources to quantify the impact, on a population, of premature death and illness from all 
diseases and injuries.  
This report presents estimates of fatal burden for Aboriginal and Torres Strait Islander 
Australians for 2010 produced as part of the Indigenous component of the Australian Burden 
of Disease Study (ABDS) at the Australian Institute of Health and Welfare (AIHW).  
The last burden of disease study that provided estimates for Aboriginal and Torres Strait 
Islander Australians was published in 2007, using 2003 data (Vos et al. 2007). This current 
study builds on the methodological developments in recent global and country burden of 
disease studies, modified for the Australian context. As a result of these methodological 
advancements, the fatal burden estimates presented in this report cannot be compared 
directly to the 2003 burden of disease estimates for Indigenous Australians.   
Fatal burden is measured in years of life lost (YLL), which is the sum of the number of years 
of life lost due to premature death from disease and injury. Fatal burden estimates presented 
in this report are described for the Aboriginal and Torres Strait Islander population for broad 
disease groups, by age and sex. Estimates of the ‘gap’ in fatal burden between Indigenous 
and non-Indigenous Australians are also reported, together with selected sub-national 
estimates (selected states and territories, remoteness and socioeconomic disadvantage).  
Fatal burden estimates presented in this report are based on mortality data adjusted for 
Indigenous under-identification. Non-Indigenous estimates presented in this report are not 
the same as estimates for the total Australian population and should not be used as such. 
Please refer to the AIHW’s report ‘Australian Burden of Disease Study: fatal burden of 
disease 2010’ (AIHW 2015) for estimates of fatal burden in the total Australian population.     
The AIHW will release a more comprehensive report on the burden of disease for Aboriginal 
and Torres Strait Islander peoples in 2016. It will update and extend this report with 2011 
estimates of fatal and non-fatal burden for more specific causes, as well as the burden 
attributable to selected risk factors.  
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Summary 
This report presents estimates of fatal burden for Aboriginal and Torres Strait Islander 
Australians for 2010. Estimates of the ‘gap’ in fatal burden between Indigenous and  
non-Indigenous Australians are also reported, together with selected sub-national estimates 
(selected states and territories, remoteness and socioeconomic disadvantage).  
Key findings 
• There were around 2,950 deaths of Indigenous Australians in 2010, resulting in almost 
100,000 years of life lost to premature mortality (YLL). 
• In 2010, the rate of fatal burden experienced by Indigenous Australians was 2.6 times the 
rate of fatal burden experienced by non-Indigenous Australians. 
• Injuries and cardiovascular diseases contributed the most fatal burden for Indigenous 
Australians (22% and 21% respectively), followed by cancer (17%), infant and congenital 
conditions (10%), gastrointestinal diseases (6%) and endocrine disorders (5%). These 
disease groups accounted for 82% of all Indigenous YLL in 2010. 
• Indigenous males had a higher proportion of YLL from injuries than Indigenous females 
(representing 26% compared to 16% of total YLL). In contrast, cancer represented a 
higher proportion of total YLL for Indigenous females than for Indigenous males (21% 
compared to 15% respectively). 
• Deaths in infants (under 1 year) contributed the most to Indigenous YLL (12% for males 
and 11% for females). This reflects the influence of age at death on the measure of fatal 
burden. The remaining majority of fatal burden in the Indigenous population is in the 
middle aged; however, the highest YLL rates per 1,000 population are in the older age 
groups (aged 70 and over), reflecting higher death rates in these age groups. 
• Infant and congenital conditions accounted for the majority of the fatal burden among 
Indigenous infants (80% for males and 85% for females). Injuries accounted for the 
majority of fatal burden among those aged 1–34. Cardiovascular diseases and cancer 
were the two biggest contributors to total YLL for Indigenous people aged 45 and over. 
Endocrine disorders (which include diabetes) were also in the top 5 causes of fatal 
burden for Indigenous people aged 45 and over. 
• The diseases contributing most to the gap in fatal burden between Indigenous and non-
Indigenous Australians were cardiovascular diseases (responsible for 27% of the gap), 
cancer (15%), injuries (14%) and endocrine disorders (10%). Together, these disease 
groups accounted for almost two-thirds of the gap in fatal burden of disease in 2010.  
• Endocrine disorders, and kidney and urinary diseases, had the highest relative 
disparities in fatal burden, with YLL rates for Indigenous Australians being 8 and 7 
times the rates for non-Indigenous Australians for these 2 disease groups respectively. 
• Rates of fatal burden among the Indigenous population were highest in the Northern 
Territory and Western Australia (of the 4 jurisdictions for which YLL estimates are 
reported: New South Wales, Queensland, Western Australia and the Northern 
Territory); and were higher in Remote and Very remote areas compared to Major cities and 
regional areas. Indigenous YLL rates were highest in areas where the Indigenous 
population was most socioeconomically disadvantaged and fell with decreasing levels of 
disadvantage. 
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1 Introduction 
This report presents estimates of the fatal burden of disease and injury for Aboriginal and 
Torres Strait Islander people, as well as estimates of the ‘gap’ in fatal burden between 
Indigenous and non-Indigenous Australians. Estimates of the non-fatal burden of disease 
will be included in a final report from the Australian Burden of Disease Study (ABDS) 2011 
for the Aboriginal and Torres Strait Islander population, expected to be released in 2016. 
This chapter provides an overview of burden of disease analyses, previous burden of disease 
studies, the ABDS 2011, and the purpose and structure of this report. 
1.1 What is burden of disease? 
Burden of disease analysis is a technique used to assess and compare the impact of different 
diseases, conditions or injuries (referred to collectively as causes) on a population. It uses 
information from a range of sources to quantify the fatal and non-fatal effects of diseases and 
injuries and combine them into a summary measure of health called the DALY—a disability-
adjusted life year. The DALY extends the concept of years of life lost (YLL) due to premature 
death to include equivalent years of ‘healthy’ life lost from living with diseases or injuries 
(quantified as years lived with disability, YLD). Burden of disease analysis also allows the 
contributions of various risk factors to be calculated, with each risk factor contribution 
known as its ‘attributable burden’. (Definitions of key terms used in burden of disease 
studies are in Box 1.1.) 
Burden of disease analysis has become the global standard for collating all useable data on 
causes of health loss to produce comparable and concise policy-relevant evidence. The ability 
to use data from a range of sources to construct a comparable measure for all diseases is a 
key strength of this approach. As such, it is possible to estimate the relative contribution of 
each disease to the total burden of disease. 
Burden of disease analysis provides a useful evidence base to support the following: 
• Monitoring of population health. Burden of disease analysis is particularly valuable for 
monitoring population health because it simultaneously quantifies the fatal and non-
fatal effects of causes of ill health. The metrics used also enable comparability across 
disease groups, individual causes and population groups. The contributions of various 
risk factors can also be quantified using the same metrics.  
• Health policy and health services planning. Burden of disease studies can provide 
valuable information to inform health policy formation and health services planning. For 
example, BoD data can show the diseases or injuries most likely to have an impact on the 
health system and health services through resulting doctor visits, hospital admissions or 
dental care. In addition, estimates of the burden attributable to specific risk factors can be 
used to develop and implement better-targeted prevention policies. 
• Assessment of the broader impact of diseases and the cost effectiveness of 
interventions. Burden of disease information can be used to measure the health impact 
of interventions and, by extension, their cost-effectiveness. It can also be useful to 
compare burden of disease information for particular diseases or risk factors with 
expenditure on treating or preventing those diseases or risk factors.  
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Box 1.1: Key terms used in burden of disease analysis 
Attributable burden: The disease burden attributed to a particular risk factor. It is the 
reduction in burden that would have occurred if exposure to the risk factor had been 
avoided. 
DALY (Disability-adjusted life year): One (1) year of healthy life lost, either through 
premature death or, equivalently, through living with ill health due to illness or injury. 
Incidence: The number of new cases (of an illness or event) occurring during a given 
period. 
Prevalence: The number of cases of a disease or injury in a population at a given time. 
YLD (Years lived with disability): A measure of the years of what could have been a 
healthy life that were instead spent in states of less than full health. 
YLL (Years of life lost): Years of life lost due to premature mortality. It is calculated by 
counting the number of deaths at each age, multiplied by the remaining life expectancy at 
this age according to a standard life table. 
Fatal burden: Burden of disease caused by mortality. Represented by YLL measure. 
Non-fatal burden: Burden of disease caused by morbidity. Represented by YLD measure. 
1.2 Previous burden of disease studies 
The first global BoD study—for the reference year 1990—developed the DALY metric and 
quantified the disease burden (and attribution to risk factors) for 8 regions of the world 
(Murray & Lopez 1996). Since then, additional global and country studies have been 
undertaken and methods have been further developed. The Global Burden of Disease Study 
2010 (hereafter referred to as GBD 2010), conducted by the Institute for Health Metrics and 
Evaluation (IHME) and other academic partners, was published in December 2012 (The 
Lancet 2012). It used updated methods to generate DALYs for 2010 and revised estimates for 
1990 and 2005. More recently, the World Health Organization (WHO) applied these methods 
(with some modifications) to revise and update global health estimates for 2000–2012 (WHO 
2014a). When preparing this current report as part of the Australian Burden of Disease Study 
(ABDS), the IHME was also updating its estimates for the 2013 reference year.  
To date in Australia, there have been two major national burden of disease studies—the first 
was published by AIHW in 1999 using 1996 data, and the second was published by AIHW 
and the University of Queensland in 2007 using 2003 data. There has also been one national 
study for Aboriginal and Torres Strait Islander people published in 2007 using 2003 data 
(Vos et al. 2007). Some states and territories have also completed burden of disease work (a 
summary of global and Australian burden of disease studies is at Appendix A). 
1.3 Australian Burden of Disease Study 2011 
In 2013, the Department of Health and the former Australian National Preventive Health 
Agency funded the AIHW to update burden of disease estimates for Australia. The 
Australian Burden of Disease Study 2011 will have several outputs, and builds on the 
AIHW’s previous burden of disease work, including providing burden of disease estimates 
for both the total Australian and Aboriginal and Torres Strait Islander populations. Where 
valid, and where capacity allows, sub-national estimates will also be produced.  
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The study will use and adapt the methods of the GBD 2010 study to quantify burden of 
disease, but using Australian data sources. The resulting estimates will thus be better aligned 
to the Australian health policy context. Methods used in other recently published burden of 
disease studies— notably the WHO’s Global Health Estimates 2012 (WHO 2014b), and the 
New Zealand Ministry of Health’s Burden of Diseases, Injuries and Risk Factors Study,  
2006–2016 (MOH 2012) are also being reviewed and incorporated into the Australian study 
where appropriate.  
Aboriginal and Torres Strait Islander disease burden 
Aboriginal and Torres Strait Islander people as a population group experience a very 
different disease burden to non-Indigenous Australians; both a higher burden as well as 
some differences in the pattern and age distribution of diseases. Indigenous Australians also 
experience much higher mortality rates than non-Indigenous Australians across all age 
groups and for all leading causes of death, and Indigenous mortality has consequently 
become a major focus of policy attention. Two of the six Council of Australian Governments 
(COAG) Closing the Gap targets for Indigenous disadvantage are mortality-related—to close 
the gap in life expectancy within a generation, and to halve the gap in mortality rates for 
Indigenous children under five by 2018.  
Burden of disease estimates for the Aboriginal and Torres Strait Islander population will 
provide evidence on the diseases and injuries currently contributing most to Indigenous 
mortality and ill health, and on the largerst gaps in health outcomes between Indigenous and 
non-Indigenous Australians. This information will be important in assisting Governments to 
develop and target interventions that can reduce the incidence of risk factors and other main 
contributors to the burden of disease and injury in the Indigenous population. 
Comparability to previous burden of disease studies 
A principle of the ABDS is to maintain as much international comparability as possible, with 
clarity around any differences, while being relevant to the Australian context. This report 
therefore draws on many of the methodological advances of recent global studies (in 
particular GBD 2010)—which differ from the methods used in the previous Indigenous 
burden of disease study in Australia (Vos et al. 2007) (refer to Box 1.2 for the main 
differences).  
This current report includes a number of improvements to methods relating specifically to 
the calculation of Indigenous fatal burden of disease estimates. Such improvements include 
adjusting for Indigenous under-identification in mortality data using direct methods based 
on national data linkage studies; reporting of two key measures of the mortality gap between 
Indigenous and non-Indigenous Australians (rate ratios and rate differences) using the direct 
age-standardisation method, which will enable future comparisons over time; and using an 
Indigenous-specific index of socioeconomic outcomes (Biddle 2013) to examine YLL 
estimates by socioeconomic disadvantage. 
As a consequence of these methodological differences, the fatal burden estimates presented 
in this report cannot be compared with estimates produced in the previous Indigenous 
burden of disease study. Therefore, comparisons over time are currently not available. 
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Box 1.2: Comparing YLL estimates with those in previous (2003) Indigenous 
Australian Burden of Disease (BoD) Study 
The YLL estimates for Indigenous Australians in the ABDS will differ to those produced in 
the 2003 Indigenous burden of disease study due to differences in the following factors: 
Cause list and ICD code allocation: The cause list provides a framework for which 
estimates of fatal and non-fatal burden are calculated. The cause list for the ABDS has been 
tailored to suit the Australian context and definitions for national reporting. Hence, the 
causes used may not align with those used in the previous Indigenous BoD study; in some 
cases the cause labels may be the same or similar, but the component causes may differ. In 
addition, ICD code selections for each cause often differ between the two studies. 
Redistribution methods: In burden of disease studies, deaths that are not coded to causes 
defined in the study’s cause list are reassigned to other causes to ensure the burden from 
these deaths is included. In this study, these are referred to as redistribution codes; in some 
other studies, they are known as ‘garbage codes’. The current Australian study uses a 
similar approach for redistribution to that used in other studies, but the algorithms (or exact 
specifications for the reassignment) are different. 
Standard life table: The current study uses the GBD 2010 standard life table to quantify the 
remaining years of life expectancy at any age. This life table has a higher life expectancy 
than the life table used in the previous Indigenous BoD study, which will contribute to 
higher estimates of YLL.  
Methods of calculating YLL: The previous Indigenous study applied age weighting and 
discounting. To be consistent with current GBD methodology, estimates in the current 
study do not apply age weighting or discounting (see Glossary).  
Adjustment for under-identification: The previous Indigenous BoD study used an indirect 
method (the generalised growth balance) to adjust Indigenous adult mortality rates. The 
current Indigenous BoD study uses direct methods to adjust for Indigenous under-
identification based on national data linkages studies. Direct methods that use data linkage 
to derive Indigenous deaths have been found to be superior to indirect methods (Barnes et 
al. 2008) and are now recommended by the Australian Bureau of Statistics (ABS 2009). 
The ‘gap’: Estimates of the Indigenous health gap in the previous Indigenous BoD study 
were produced using an indirect standardisation approach, in which the comparison 
population was the total Australian population. The current study calculated estimates of 
the mortality gap using direct age-standardisation methods in which the comparison 
population is the non-Indigenous population. Direct age-standardisation enables multiple 
comparisons and can be used for time series analyses. Two measures of the gap are 
reported (rate differences and rate ratios) which provide different information—causes that 
have the largest absolute disparities, and those that  have the greatest relative disparities. 
More details on the cause list, redistribution of deaths, standard life table, adjustment for 
Indigenous under-identification and measures of the mortality gap are described in Chapter 
2, ‘Methods, data sources and data quality’, and in the Appendixes. 
1.4 Purpose and structure of this report 
This is the first report of results produced for the Aboriginal and Torres Strait Islander 
population from the Australian Burden of Disease Study. It presents estimates of the fatal 
burden of disease for Aboriginal and Torres Strait Islander people, as well as the ‘gap’ in 
fatal burden between Indigenous and non-Indigenous Australians for the 2010 reference 
year. The 2010 fatal burden estimates use the average of three years of deaths data 
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combined—2009, 2010 and 2011. The fatal burden is measured in years of life lost (YLL), 
which is the sum of the number of years of life lost due to premature death from disease and 
injury. 
A report presenting estimates of the fatal burden for the Australian population has already 
been published—Australian Burden of Disease Study: fatal burden of disease 2010 (AIHW 2015). 
Reports covering estimates of fatal and non-fatal burden in the Australian population and 
Aboriginal and Torres Strait Islander population will be prepared for the 2011 reference 
period, and will be published in 2016. 
Note that the terms ‘Indigenous Australians’ and ‘Indigenous population’ have been used 
interchangeably throughout this report to refer to the Aboriginal and Torres Strait Islander 
population in Australia.  
This report includes estimates and rankings for disease groups, by age and sex. Estimates for 
specific causes are not included in this report as the cause list and methods may be further 
refined before full estimates for 2011, including for specific causes, are published. Any 
changes to the cause list may result in changes to the number of deaths and patterns of YLL 
estimates by both disease group and specific cause. But the changes will be less apparent at 
the disease group level than at the finer specific cause level—which is why this report 
presents YLL estimates by disease group.  
The importance of social determinants of health (such as income/poverty, education and 
employment) to both the health of the Aboriginal and Torres Strait Islander population, as 
well as to the health ‘gap’ and health inequalities between the Indigenous and non-
Indigenous populations, is well recognised. In this report (see Chapter 5), results are 
disaggregated by a socioeconomic disadvantage as a way of showing disparities in 
Indigenous fatal burden across different social and economic groups. The importance of 
social determinants of health for Indigenous burden of disease (and for burden of disease 
analysis more broadly) will be discussed further in the forthcoming (2016) final report 
published from the ABDS on the burden of disease in the Indigenous population. 
This report on the fatal burden of disease for Aboriginal and Torres Strait Islander people is 
structured as follows: 
Chapter 2: Methods and data sources used to derive YLL estimates reported, including 
methods for redistributing causes of death, adjusting for Indigenous under-identification in 
mortality data and measuring the mortality gap.  
Chapter 3: National estimates of the fatal burden (YLL) of disease and injury for Indigenous 
Australians by age group, sex and disease group. 
Chapter 4: National estimates of the gap in the fatal burden of disease between Indigenous 
and non-Indigenous Australians by age group, sex and disease group.  
Chapter 5: Sub-national estimates of Indigenous YLL and the gap for selected states and 
territories, by remoteness and by quintile of socioeconomic disadvantage. 
Chapter 6: International comparisons of fatal burden (YLL) for the Aboriginal and Torres 
Strait Islander population in Australia and the Māori population in New Zealand from the 
recent New Zealand Burden of Diseases, Injuries and Risk Factors Study, 2006–2016. 
The Appendixes in this report include more detailed information on various components of 
the methodology and data sources, including the standard life table, cause list, redistribution 
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methods, methods used to adjust Indigenous deaths, and methods used to measure the gap 
between Indigenous and non-Indigenous Australians.  
Supplementary tables used to support the analyses and figures presented in this report are 
provided under the ‘Additional materials’ tab for this report on the AIHW website 
<www.aihw.gov.au>.  
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2 Methods, data sources and data quality 
A complete set of mortality data (by age, sex, Indigenous status and other key attributes, 
such as cause of death) and a standard life table are the key requirements for producing 
estimates of years of life lost (YLL).  
This chapter summarises information on the data sources and methods used for estimating 
YLL presented in this report, including methods specific to estimating fatal burden of disease 
and injury for the Aboriginal and Torres Strait Islander population. Detailed information on 
data sources, methods and technical notes are included in the Appendixes of this report.  
2.1 Years of life lost  
YLL estimates measure the impact of dying prematurely; that is, the fatal component of 
burden of disease. A critical step for estimating YLL is to first compile the total number of 
deaths in a specific year, by age and sex. Each death record is then weighted according to the 
remaining life expectancy at that age of death, which is derived from the standard life table 
used (see ‘Standard life table’ in Section 2.2 below). The weighted deaths are summed and 
the result is the total number of YLL from all deaths. 
YLL = number of deaths × remaining life expectancy at the age of death (according to the standard 
life table) 
The calculation of YLL in this report used deaths tabulated by single year of age at death and 
a terminal age of 104 years (which was the oldest age of death recorded for Indigenous 
Australians in mortality data for the reference period of this study). 
2.2 Data sources and inputs 
Deaths data 
Analysis of burden of disease takes into account all deaths that occur in a population during 
a specified period. This report provides YLL estimates for the reference period 2010. It is 
based on the annual average number of deaths that occurred over the 2009–2011 period. 
Mortality data come from the AIHW’s National Mortality Database. This database comprises 
information about the causes of death for, and other characteristics of, individuals who have 
died, such as sex, age at death, Indigenous status and area of usual residence. The cause-of-
death data are sourced from the Registrars of Births, Deaths and Marriages in each state and 
territory and the National Coronial Information System, and are coded to the WHO’s 
International Classification of Diseases (ICD) by the Australian Bureau of Statistics (ABS).  
Indigenous deaths from all states and territories are included in national burden of disease 
estimates presented in this report, adjusted for Indigenous under-identification in mortality 
data (see ‘Adjusting Indigenous deaths for under-identification’ in Section 2.4). 
For more information on deaths data and the National Mortality Database, see Appendix B. 
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Population data 
Aboriginal and Torres Strait Islander population estimates as at 30 June 2009, 2010 and 2011 
(based on the 2011 Census), were used to calculate Indigenous YLL rates presented in this 
report. Non-Indigenous population estimates were calculated by subtracting the Aboriginal 
and Torres Strait Islander population estimates from the total Australian population 
estimates for the same years. 
For the calculation of Indigenous YLL rates by remoteness, experimental Indigenous 
population estimates calculated by the AIHW were used (for 5 remoteness categories, by  
5-year age group and sex, as at 30 June 2009, 2010 and 2011). These estimates were calculated 
based on the ABS’s 2011 Census Estimated Resident Population (ERP) for the Aboriginal and 
Torres Strait Islander population. The ABS has released the 2011 ERP for the Indigenous 
population for only 3 remoteness categories (Major cities, Inner/Outer regional combined, and 
Remote/Very remote combined)—therefore these data could not be used to calculate 
Indigenous YLL rates for the 5 remoteness categories individually.  
For the calculation of Indigenous YLL rates by socioeconomic disadvantage, the 2011 
Aboriginal and Torres Strait Islander Estimated Resident Population (ERP) at the Statistical 
Area 2 (SA2) level was used. 
For the calculation of age-standardised YLL rates, the Australian Estimated Residential 
Population as at 30 June 2001 (based on the 2001 Census) was used as the standard 
population (current standard in Australia). 
Standard life table 
The standard life table is a key component of burden of disease studies. A standard life table 
corresponds to the aspirational or maximum life span for an individual in good health—it is 
not necessarily the actual life table of the population being studied. It is used to produce 
estimates of life expectancy at each age to indicate the number of years of life that are lost 
from dying at a specific age.  
A standard life table is used to enable comparisons between population groups and across 
time. The ABDS uses the standard life table used in GBD 2010 (Murray et al. 2012) in 
calculating YLL. This life table is used for both national and Indigenous estimates to 
maintain comparability. The GBD 2010 standard life table is based on the lowest observed 
age-specific death rates, capturing mortality patterns in all countries except those with very 
small populations, and covering all age ranges. The result is a hypothetical life table giving 
life expectancy at birth to be 86.0 years for both males and females. This is higher than the 
estimated life expectancy at birth for Indigenous Australians in 2010–2012 (that is, 69.1 and 
73.7 years for Indigenous males and females, respectively).  
(See Appendix B for more information on the standard life table, comparisons of different 
standard life tables used in global and previous Australian studies, and analysis of the 
impact of using these different standard life tables on resulting Indigenous YLL.) 
Index of socioeconomic disadvantage 
The 2011 Indigenous Relative Socioeconomic Outcomes (IRSEO) index was used in this 
report to examine variation in the fatal burden of disease for the Indigenous population by 
level of socioeconomic disadvantage (Biddle 2013). The index incorporates nine variables 
from the 2011 Census of Population and Housing that measure employment, occupation, 
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education, income and housing. The IRSEO index was originally calculated at the 
Indigenous Area level (following the ABS’s Australian Statistical Geography Standard) and 
has been converted to Statistical Area Level 2 (SA2) using a population-weighted 
concordance.  
The IRSEO index is considered to be more suitable for use for the Indigenous population 
than traditional measures of socioeconomic disadvantage used in Australia such as the 
Socio-Economic Indexes for Areas (SEIFA). SEIFA scores for each geographical unit are 
calculated based on the socioeconomic characteristics of the entire population and thus they 
may not accurately reflect levels of socioeconomic disadvantage in the Indigenous 
population. 
Indigenous population numbers by SA2 and age group are needed to calculate age-
standardised YLL rates by socioeconomic disadvantage. However, these numbers were not 
available to the AIHW at the time of writing this report. As a result, only crude YLL rates are 
presented.  
Despite these difficulties, it is still possible to examine differences in the general pattern and 
variation by socioeconomic disadvantage in the fatal burden of disease for the two 
population groups. A non-Indigenous specific index of socioeconomic outcomes has been 
developed by Biddle (2013) which has been used to calculate crude YLL rates by 
socioeconomic disadvantage for the non-Indigenous population. The 2011 re-scaled Pooled 
Non-Indigenous Relative Socioeconomic Outcomes index (PNIRSEO) uses a ranking for the 
socioeconomic disadvantage of non-Indigenous Australians in each Indigenous Area, which 
is then converted to SA2 values using population weighted concordances (Biddle 2013). 
While not directly comparable to the IRSEO Index, it enables an examination of variation in 
fatal burden by socioeconomic advantage in the non-Indigenous population. 
See Appendix C for more information on the various socioeconomic disadvantage indexes 
available and the rationale for those used in this report to examine socioeconomic disparities 
within the Indigenous population, as well as comparisons with the non-Indigenous 
population. 
Cause list 
All deaths, regardless of their causes, are counted when estimating fatal burden. The cause 
list details the specific diseases and injuries for which estimates of the number of YLL, YLD 
and DALYs will be made. The cause list is a classification which, in principle, is a set of 
mutually exclusive and collectively exhaustive categories of disease and injury.  
An Australian cause list was developed specifically for this report, with disease and cause 
groups being tailored to meet Australian and Indigenous health policy needs, and fit with 
the current health monitoring environment. 
The resulting cause list is hierarchical and has two levels. The highest level contains 17 
disease groups under which around 175 causes are classified. This report presents YLL 
estimates by disease group rather than by cause. A list of disease groups can be found in 
Appendix D (Table D.1), including short labels for each disease group (e.g. ‘Cancer’ for 
‘Cancer and other neoplasms’) which are used in some parts of this report.  
Consistent with previous burden of disease studies, the ABDS used the underlying cause of 
death (UCOD) to classify each death to a cause in the cause list. Use of the UCOD as the sole 
source of cause of death information assigns the entire fatal burden for each death to a single 
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cause. This does not explicitly account for situations where more than one disease 
contributed to the death. Further development work may be undertaken to assess the use of 
associated causes of death or other information to account for this more complex situation.  
More information about the cause list is provided in Appendix D. 
2.3 Methods for redistribution of deaths 
There are several ICD-10 codes that are not valid or appropriate causes of death for burden 
of disease analysis. Some examples are: 
• causes that can be considered as implausible as the underlying cause of death, such as 
hypertension and paraplegia 
• intermediate causes: casuses that have a precipitating cause such as septicaemia and 
pneumonitis 
• immediate causes of death that occur in the final stages of dying, such as cardiac arrest 
and respiratory failure 
• causes that are ill-defined or unspecified; for example, ill-defined digestive cancer and 
ill-defined digestive diseases. 
Despite their high quality, the Australian deaths data are affected by these codes.  
To quantify their contribution to the fatal burden, deaths coded to these codes must be 
reallocated to one or more of the conditions defined on the cause list (target causes) 
according to what would be a more probable underlying cause. This process is referred to as 
‘redistribution’. 
Some simple redistribution methods were applied in the previous Australian burden of 
disease studies; these methods were further developed for GBD 2010, and in some cases 
were used in calculating YLL estimates.  
The AIHW recently investigated four redistribution algorithms based on, respectively, direct 
evidence, direct multiple causes of death (MCOD) analysis, indirect MCOD analysis, and 
proportionate allocation. Three of these methods (the exception being direct MCOD analysis) 
have been used to redistribute both Indigenous and non-Indigenous deaths in the ABDS. 
Using the three redistribution methods for the Australian redistribution causes (Appendix 
Table D.4), approximately 8% of Indigenous deaths and 10% of all Australian deaths were 
identified for redistribution. This compares with 18% of Australian deaths that were 
identified for redistribution using GBD 2010 methods. The difference is largely due to the 
cause list: some of the causes of death that were redistributed in GBD 2010 were directly 
allocated to a cause in the ABDS. 
A detailed description of these redistribution methods, their application to Indigenous 
deaths, and the impact on resulting YLL, is provided in Appendix D.  
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2.4 Methods specific to Indigenous fatal burden 
estimates 
Adjusting Indigenous deaths for under-identification 
Over the last decade, a number of studies have been undertaken aimed at improving the 
quality of Indigenous status information in Australian health and vital statistics collections. 
Under the National Indigenous Reform Agreement, the ABS has made improvements to 
Indigenous enumeration procedures for the Census, and the AIHW has published best 
practice guidelines for the collection of Indigenous status in health data collections (AIHW 
2010). States and territories agreed to improve the collection of Indigenous status 
information in key health data sets, including through implementing the best practice 
guidelines, and adopting the standard Indigenous status question and recording categories 
in health data collection and information systems (COAG 2008). 
Despite these improvements, limitations still remain with the quality of Indigenous status 
data. Every year, a number of deaths of Aboriginal and Torres Strait Islander people are not 
identified as such when they are registered (ABS 2013c). This may arise from the non-
reporting of a deceased person’s Indigenous status on the death registration form, or from 
incorrect identification of a deceased person’s Indigenous status (recording a person as non-
Indigenous when they are Indigenous, and vice versa). The degree of under-identification 
can vary by age, state/territory, remoteness and over time. This under-identification means 
the number of deaths recorded as Indigenous is an underestimate of the true levels of 
mortality in that population, and consequently is also an underestimate of the mortality gap 
between Indigenous and non-Indigenous Australians. 
Since the last Indigenous Australian burden of disease study, the AIHW and ABS have made 
advances in the assessment of under-identification in mortality data using data linkage 
methods. The ABS’s Census Data Enhancement Indigenous Mortality Study (2011–12) linked 
Census records with death registration records. The AIHW’s Enhanced Mortality Database 
project (2008–2010) linked registered deaths with Indigenous death records from 
administrative data sources including residential aged care data, hospital data and perinatal 
data. Both of these studies produced mortality correction factors that can be used to adjust 
for Indigenous under-identification in Australian mortality data.  
The ABS and AIHW data linkage studies have strengths and weaknesses (see Appendix E). 
While both studies calculate age-specific adjustment factors at the national level, adjustment 
factors produced by state/territory and remoteness do not include an age adjustment (due to 
small numbers). In addition, both studies do not include cause-of-death information or 
socioeconomic data items, and thus were not able to yield adjustment factors by cause of 
death or socioeconomic disadvantage.  
The AIHW study produced adjustment factors for all 8 states and territories and 5 
remoteness categories; the ABS study produced state/territory adjustment factors for New 
South Wales, Queensland, Western Australia and the Northern Territory individually, and a 
combined adjustment factor for the other four jurisdictions (Victoria, South Australia, 
Tasmania and the Australian Capital Territory). Remoteness adjustment factors from the 
ABS study are only available for 2 combined categories: Major cities/Inner regional combined, 
and Outer regional/Remote/Very remote combined. 
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Based on advice from the Indigenous Reference Group (IRG) and the ABS, adjustment 
factors from the 2011–12 ABS Census Data Enhancement Indigenous Mortality Study have 
been used to adjust Indigenous deaths for the calculation of YLL estimates presented in this 
report, with the exception of YLL estimates by remoteness, which are based on adjustment 
factors from the AIHW’s Enhanced Mortality Database study (2008–10).  
The ABS national and state/territory adjustment factors were chosen as they take into 
account under-identification in both mortality data and population data, and therefore, in 
theory, provide consistency in the numerator and denominator used in Indigenous YLL 
calculations. The ABS adjustment factors are also the official estimates of Indigenous 
mortality coverage in Australia. Furthermore, sensitivity analyses undertaken by the AIHW 
looking at the impact of using the different adjustment factors available (ABS compared to 
AIHW) on the resulting Indigenous YLL estimates and measures of the gap showed that at 
the national level, the age patterns and disease rankings remained consistent using either set 
of adjustment factors (see Appendix E for more detail).   
AIHW remoteness adjustment factors have been used to calculate YLL estimates by 
remoteness due to a number of limitations with the ABS remoteness adjustment factors. The 
ABS combined adjustment factors for Major cities/Inner regional and Outer 
regional/Remote/Very remote are not considered useful to policymakers for examining 
mortality disparities by remoteness, given the wide variation between the five remoteness 
categories, and because the chosen groupings of remoteness (in particular, the combining of 
Outer regional with Remote and Very remote) mask any mortality disparities by remoteness— 
they do not follow the typical categories of non-remote and remote.  
It is important to note that YLL estimates by remoteness presented in Section 5.2 of this 
report are not comparable to YLL estimates presented in other sections. This is because the 
former have been adjusted using factors from the AIHW Enhanced Mortality Database 
study, while the latter were adjusted using factors from the ABS CDE Indigenous Mortality 
Study. Total numbers of adjusted deaths and YLL should be sourced from tables for national 
results which are based on the ABS adjustment factors.  
State and territory Indigenous YLL estimates are not presented for Victoria, South Australia, 
Tasmania or the Australian Capital Territory, due to the small number of Indigenous deaths 
reported for these jurisdictions, and because individual state/territory adjustment factors are 
not available from the ABS for these states and territories. In addition, use of the ABS 
combined adjustment factor for these states and territories results in an implausibly high 
Indigenous YLL estimate for the four jurisdictions combined, and disaggregation of the 
combined adjustment factor to produce individual jurisdictional estimates also produces 
somewhat implausible YLL results.  
Despite the attempt to remove bias in YLL results through adjustments made to Indigenous 
deaths, there is still a degree of uncertainty around the true level of mortality among 
Indigenous Australians. The adjustments themselves inherently introduce a degree of 
uncertainty. A long-term strategy to improve Indigenous mortality estimates is through 
improvements to the data at the collection phase so that fewer adjustments will be necessary 
for Indigenous mortality reporting in the future. 
Further information about the methods used to adjust Indigenous deaths for under-
identification in this report, including the adjustment factors used and sensitivity analyses 
undertaken by the AIHW to inform the choice of adjustment factors for this study, can be 
found in Appendix E. 
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Measuring the mortality gap between Indigenous and non-
Indigenous Australians 
There is strong interest in measuring the health ‘gap’ between Indigenous and non-
Indigenous Australians for the ABDS, given the gap in the life expectancy between these two 
populations. As a general principle, in the ABDS, the methods used to produce Indigenous 
burden-of-disease estimates will be as consistent and comparable as possible with the 
methods used to produce national estimates. For fatal BoD estimates, as presented in this 
report, the same data source, methods and years of data have been used for both the 
Indigenous and total populations. The only difference is in the reporting age groups 
presented for YLL. 
For the most accurate estimation of the gap, comparisons should be made with the non-
Indigenous population rather than the total Australian population (which includes the 
Indigenous population). Consequently, for the ABDS, estimates of fatal and non-fatal burden 
will be calculated where possible for the Indigenous and non-Indigenous populations 
separately. This report presents preliminary results for the gap in fatal burden between 
Indigenous and non-Indigenous Australians at the disease group level.  
As the Indigenous population has a younger age profile than the non-Indigenous 
population, YLL rates must be age-standardised to adjust for differences in age structure 
between the two populations being compared. The YLL gap has been measured using direct 
age-standardisation, which applies the age-specific YLL rates of the Indigenous and non-
Indigenous populations to the current Australian standard population (the Australian 
Estimated Residential Population as at 30 June 2001, based on the 2001 Census). The direct 
method has been used as it enables multiple comparisons (for example, cause by sex or cause 
by state/territory) and can be used for time series analyses. A limitation of this method is 
that the direct method can become less stable when based on a small number of deaths and 
consequently produce less reliable results—this should be kept in mind when interpreting 
gap results for less common causes of death. 
For reporting of the gap in YLL between the Indigenous and non-Indigenous populations, 
rate differences, as well as ‘rate ratios’ (based on directly age-standardised rates), are 
presented. Rate differences provide a measure of the absolute gap (or difference) between 
two populations, while rate ratios take scale into account and are a measure of the relative 
gap (or difference) between two population groups. Both measures are considered useful 
when examining health inequalities because they provide different information—rate 
differences tell us which leading causes of the gap should be targeted in order to reduce the 
overall mortality gap, whereas rate ratios tell us which causes have the greatest relative 
disparities between the Indigenous and non-Indigenous populations. 
The primary statistics presented in this report on the leading causes of the mortality gap are 
therefore based on rate differences (using the measure of percentage contribution of each 
disease to the total rate difference). In addition, information is presented on the diseases with 
the highest rate ratios, representing the largest relative disparities in fatal burden between 
the Indigenous and non-Indigenous populations. When interpreting results, please note that 
a large rate ratio does not necessarily imply that a disease has a large absolute impact. 
Diseases that are rare in one population can produce large rate ratios in the comparative 
population, irrespective of the level of mortality.  
More information about the methods used to measure the gap for YLL estimates presented 
in this report can be found in Appendix F. 
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Overcoming small numbers 
An important consideration for Indigenous burden of disease is the robustness and 
reliability of estimates produced, and the level of disaggregation that the data will support 
given the small size of the Indigenous population and consequently the relatively small raw 
number of Indigenous deaths each year compared with the very much larger non-
Indigenous population. To ensure validity of the results, the AIHW has aggregated several 
years of mortality data, age groups, and disease groups in producing Indigenous YLL 
estimates. In some cases the level of disaggregation used to report Indigenous estimates is 
broader than that reported for the total Australian population. This is discussed further 
below. 
Combining years of deaths data  
The number of deaths due to any particular cause varies from year to year. These 
fluctuations are more noticeable for causes that are less common and in Indigenous deaths 
that are often small in number. To reduce the impact of random fluctuations, three years of 
deaths data were summed, then divided by three, to produce average annual YLL estimates.  
This provides greater stability in Indigenous estimates of YLL and rates for: 
• causes of death that are rare  
• causes that occur episodically 
• reporting at disaggregated levels (for example, by the level of cause group, and for sub-
national estimates). 
Mortality and YLL estimates presented in this report are based on deaths that occurred from 
2009 to 2011.  
Reporting age groups 
The standard reporting age groups used for reporting Indigenous YLL estimates at the 
disease group level in this report are: less than 1; 1–14; 15–24; 25–34; 35–44; 45–54; 55–64;  
65–74; and 75 and over. These age groups are slightly different to those reported for the total 
Australian population (where the 1–14 group is split into 1–4 and 5–14, and the highest age 
group is 85 and over) in order to minimise the number of small cells. However, where 
numbers support the use of more detailed age groups (such as figures presenting total YLL 
rather than YLL by disease group), Indigenous YLL estimates are reported using the same 
age groups as reported for the total Australian population.  
Reporting disease groups 
Of the 17 disease groups included in the Australian cause list, 14 disease groups are reported 
separately, and the remaining 3 disease groups (reproductive and maternal conditions, sense 
organ disorders and oral disorders) have been combined under ‘other disease groups’ due to 
the small number of deaths reported for these diseases. For sub-national estimates, only the 
top 10 disease groups are presented in most figures and tables due to small numbers. 
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3 National results: Indigenous YLL 
This chapter presents YLL estimates for the Aboriginal and Torres Strait Islander population 
for the reference year 2010 (based on the average annual number of deaths for the 3-year 
period 2009–2011). Comparisons with the non-Indigenous population are primarily included 
in Chapter 4. National estimates presented in this chapter include deaths from all states and 
territories and have been adjusted to account for Indigenous under-identification in 
mortality data (see Appendix E for further information).  
3.1 Overall Indigenous fatal burden by age and sex 
• In 2010, there were 2,950 deaths of Aboriginal and Torres Strait Islander people in 
Australia (after adjustment for Indigenous under-identification in mortality data). This 
resulted in a total of around 98,282 YLL; that is, the total fatal burden experienced from 
premature death.  
• Indigenous males experienced the majority of the total fatal burden (58%), equating to  
57,259 YLL, compared with 41,024 YLL for Indigenous females. This reflects both the 
higher number of deaths of Indigenous males compared to Indigenous females, and also 
the fact that Indigenous males tend to die at younger ages than Indigenous females, thus 
resulting in more years of life lost due to premature mortality. 
Fatal burden also differs across age groups, being influenced by both the number of deaths 
and life expectancy (in the standard life table) at that age. Analysis of the number and 
proportion of YLL for the Indigenous population by age group (Figure 3.1) shows that:  
• Deaths in infants (under 1 year) contributed the largest number of YLL for the 
Indigenous population (12% of total male YLL and 11% of total female YLL). This reflects 
the relatively high number of deaths occurring in infancy—which incur the largest 
number of potential years of life lost. 
• After infancy, a considerable component of the fatal burden in the Indigenous 
population is experienced in the middle-aged, also due to the high number of deaths 
occurring in these ages. YLL was highest for Indigenous males aged 45–49 (5,187 YLL) 
and for Indigenous females aged 50–54 (3,736 YLL). 
• This pattern is quite different to that observed in the total Australian population, in 
which there is a general increase in the number of YLL with increasing age (to around 84 
years) (AIHW 2015). Despite the years of life remaining at older ages being smaller than 
at younger ages, this increase is due to the much higher number of deaths occurring in 
the older ages in the non-Indigenous population, giving rise to the greater fatal burden 
in the older age groups.  
• Overall, these patterns in YLL by age group drive observed differences in life expectancy 
between Indigenous and non-Indigenous Australians (that is, Aboriginal and Torres 
Strait Islander people tend to die at much younger ages than non-Indigenous 
Australians). 
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Notes 
1. This figure is based on data in a supplementary table available online—Table S3.1. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.1: YLL for Indigenous Australians, by age and sex, 2010 
Figure 3.2 shows the YLL rates for Indigenous males and females; that is the YLL per 1,000 
population in each age-sex group. With the exception of infants (mentioned below), it 
predominantly shows that from age 10–14, YLL rates generally increased with age. In 
particular: 
• The YLL rate among Indigenous infants was high (781 per 1,000 population for males 
and 534 per 1,000 for females), consistent with the relatively high number of deaths in 
this age group.  
• For Indigenous males, the rate of fatal burden increased steadily to ages 80–84 where it 
peaked at 988 YLL per 1,000 population.  
• For Indigenous females, the rate of fatal burden was consistently lower than the rate for 
Indigenous males except between the ages of 1 and 14. The YLL rate for Indigenous 
females increased with age, peaking at 916 YLL per 1,000 population for those aged 85 
and over. The small number of Indigenous deaths occurring in those aged 75 and over 
may make estimates for these older age groups less reliable. 
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Notes 
1. This figure is based on data in a supplementary table available online—Table S3.1. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.2: Age-specific rates of YLL for Indigenous Australians, by age and sex, 2010 
3.2 Indigenous fatal burden by disease group 
Analysis of YLL for the Indigenous population by disease group for 2010 (Figure 3.3 and 
Table 3.2) shows that: 
• Injuries and cardiovascular diseases contributed most to the fatal burden for Indigenous 
Australians in 2010 (22% and 21% of YLL respectively). These were followed by cancer 
(17%), infant and congenital conditions (10%), gastrointestinal diseases (6%) and 
endocrine disorders (5%). These disease groups accounted for 82% of all YLL in 2010. 
• These results differ when the contribution of each disease group is examined by number 
of deaths alone. The highest number and proportion of deaths were due to 
cardiovascular diseases (25%), followed by cancer (22%) and injuries (14%). This reflects 
the fact that individuals largely die from injuries at a young age. 
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Notes 
1. This figure is based on data in Table 3.2. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.3: Proportion of deaths and YLL for Indigenous Australians, by disease group, 2010 
3.3 Do the leading causes of fatal burden differ by 
sex?  
• In 2010, for most disease groups, Indigenous males experienced a greater share of fatal 
burden (YLL) than Indigenous females (Table 3.1).  
• Indigenous males contributed to 70% of the total fatal burden due to injuries and 65% of 
the fatal burden due to mental illnesses and behavioural disorders.  
• Indigenous females contributed more of the fatal burden than Indigenous males for 
chronic musculoskeletal disorders (66%) and kidney and urinary disease (57%). 
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Table 3.1: Number and proportion of YLL for Indigenous Australians, by disease group and sex, 
2010 
  Males 
 
Females 
 
Persons 
Disease group Number Per cent  Number Per cent  Number Per cent 
Injuries 15,129  69.8 
 
6,558  30.2 
 
21,687  100.0 
Cardiovascular diseases 12,366  60.1 
 
8,208  39.9 
 
 20,574  100.0 
Cancer and other neoplasms 8,540  50.4 
 
8,420  49.6 
 
16,960  100.0 
Infant and congenital conditions 5,853  57.9 
 
4,264  42.1 
 
10,117  100.0 
Gastrointestinal diseases 3,372  55.8 
 
2,673  44.2 
 
6,045  100.0 
Endocrine disorders 2,601  49.1 
 
2,695  50.9 
 
5,295  100.0 
Respiratory diseases 2,225  50.0 
 
2,223  50.0 
 
4,448  100.0 
Infections 2,019  62.3 
 
1,224  37.7 
 
3,243  100.0 
Kidney and urinary diseases 1,315  43.4 
 
1,713  56.6 
 
3,029  100.0 
Neurological conditions 1,492  55.6 
 
1,192  44.4 
 
2,684  100.0 
Mental illnesses and behavioural disorders 1,359  64.8 
 
737  35.2 
 
2,096  100.0 
Blood and metabolic disorders 665  54.0 
 
566  46.0 
 
1,231  100.0 
Chronic musculoskeletal disorders 196  34.4 
 
374  65.7 
 
569  100.0 
Skin disorders 113  55.4 
 
92  45.1 
 
204  100.0 
All other disease groups 16  15.8 
 
85  84.2 
 
101  100.0 
All diseases 57,259  58.3 
 
41,024  41.7 
 
98,282  100.0 
Notes 
1. YLL for 2010 are the annual average of 2009–2011 and are adjusted using ABS adjustment factors (see Appendix E).  
2. The numbers may not add to totals for all diseases due to rounding. 
Source: AIHW analysis of the AIHW National Mortality Database. 
In terms of the ranking of disease groups contributing the most to Indigenous YLL in 2010 
(Table 3.2): 
• For Indigenous males, injuries contributed most to the fatal burden (26%), followed by 
cardiovascular diseases (22%) and cancer (15%).  
• The same three disease groups were also the largest contributors to the fatal burden for 
Indigenous females, although ranked differently. For females, cancer ranked first and 
contributed 21% to the total fatal burden, followed by cardiovascular diseases (20%) and 
injuries (16%). 
• Injuries contributed a much higher proportion of YLL for Indigenous males compared to 
Indigenous females (26% compared to 16%), while cancer contributed a much higher 
proportion of YLL for Indigenous females (21% compared to 15% for Indigenous males).  
• The proportions of YLL for Indigenous males and females were similar for most other 
disease groups.  
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Table 3.2: Number and proportion of deaths and YLL for Indigenous Australians, by disease group and sex, 2010 
  Males 
 
Females 
 
Persons 
  Deaths YLL 
 
Deaths YLL 
 
Deaths YLL 
Disease group Number Per cent Number Per cent   Number Per cent Number Per cent   Number Per cent Number Per cent 
 Injuries  280   17.4  15,129   26.4  
 
124  9.2  6,558  16.0  
 
404  13.7  21,687  22.1 
 Cardiovascular diseases  419   26.0  12,366   21.6  
 
328  24.4  8,208  20.0  
 
746  25.3  20,574  20.9  
 Cancer and other neoplasms  333   20.7  8,540   14.9  
 
313  23.3  8,420  20.5  
 
646  21.9  16,960  17.3  
 Infant and congenital conditions  70  4.3  5,853   10.2  
 
51  3.8  4,264  10.4  
 
121  4.1  10,117  10.3  
 Gastrointestinal diseases  96  6.0  3,372  5.9  
 
82  6.1  2,673  6.5  
 
178  6.0  6,045  6.2  
 Endocrine disorders  98  6.1  2,601  4.5  
 
110  8.2  2,695  6.6  
 
208  7.1  5,295  5.4  
 Respiratory diseases  91  5.7  2,225  3.9  
 
99  7.4  2,223  5.4  
 
190  6.4  4,448  4.5  
 Infections  50  3.1  2,019  3.5  
 
38  2.8  1,224  3.0  
 
88  3.0  3,243  3.3  
 Kidney and urinary diseases  48  3.0  1,315  2.3  
 
72  5.4  1,713  4.2  
 
120  4.1  3,029  3.1  
 Neurological conditions  54  3.3  1,492  2.6  
 
68  5.1  1,192  2.9  
 
122  4.1  2,684  2.7  
 Mental illnesses and behavioural 
disorders  36  2.3  1,359  2.4  
 
19  1.4  737  1.8  
 
55  1.9  2,096  2.1  
 Blood and metabolic disorders  23  1.4  665  1.2  
 
19  1.4  566  1.4  
 
42  1.4  1,231  1.3  
 Chronic musculoskeletal disorders  7  0.4  196  0.3  
 
13  1.0  374  0.9  
 
21  0.7  569  0.6  
 Skin disorders  4  0.2  113  0.2  
 
4  0.3  92  0.2  
 
8  0.3  204  0.2  
 All other disease groups   <3   <0.1  16   <0.1  
 
 <3   <0.1  85  0.2  
 
 <3   <0.1  101  0.1  
 All diseases  1,608  100.0  57,259  100.0  
 
1,342  100.0  41,024  100.0  
 
2,950  100.0  98,282  100.0  
Notes 
1. Number of deaths and YLL for 2010 are the annual average of 2009–2011, and are adjusted using ABS adjustment factors (see Appendix E).  
2. The numbers may not add to totals for all diseases due to rounding. 
3. At the time of writing this report AIHW guidelines, to ensure confidentiality, required the suppression of cells based on less than three deaths. In this table these cells are represented by <3. 
Source: AIHW analysis of the AIHW National Mortality Database.
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As we saw in section 3.2, the proportion of deaths due to a disease group may not always 
equate to the proportion of YLL caused by the disease group. This reflects the influence of 
age at death on the measure of fatal burden—deaths at young ages contribute more years of 
life lost per death. Differences between proportion of Indigenous YLL and proportion of 
Indigenous deaths are shown in Figure 3.4 for the five leading causes of fatal burden in the 
Indigenous population. In particular: 
• Deaths due to infant and congenital conditions contributed a substantial proportion of 
Indigenous YLL (10% for both males and females), however, they made up only 4% of 
Indigenous male and female deaths.  
• Similarly, while 26% of YLL for Indigenous males and 16% of YLL for Indigenous 
females were due to injuries, they only accounted for 17% and 9% of deaths respectively. 
 
Notes  
1. This figure is based on data in Table 3.2.  
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.4: Proportion of deaths and YLL for top five disease groups (as ranked by Indigenous male 
YLL), Indigenous Australians, by sex, 2010 
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3.4 Do the leading causes of fatal burden differ by 
age group? 
This section presents the number, proportion and ranking of Indigenous YLL by disease 
group and age group in 2010 (figures 3.5 to 3.8). 
• The disease group contributing the majority of fatal burden among Indigenous infants 
(aged less than 1 year) was infant and congenital conditions (which includes causes such 
as pre-term birth complications, birth trauma and congenital defects). This disease group 
was also the second leading contributor to fatal burden among Indigenous Australians 
aged 1–14. 
• The leading cause of fatal burden among Indigenous males and females aged 1–34 was 
injuries. Injuries was also a leading cause of YLL among Indigenous males aged 35–44 
(contributing a similar proportion of YLL as cardiovascular diseases in this age group). 
• Cardiovascular diseases contributed the most YLL among Indigenous males aged 35–64 
and Indigenous females aged 35–54.  
• Cancer and other neoplasms was the leading cause of fatal burden among Indigenous 
males aged 65–74 and Indigenous females aged 55–74. 
• Endocrine disorders were in the top 5 causes of fatal burden for Indigenous males and 
females aged 45 and over. 
• For Indigenous females, kidney and urinary conditions were in the top 5 conditions for 
those aged 55–74.  
• Mental and behavioural disorders featured in the top 5 leading causes of fatal burden for 
Indigenous males aged 25–34 and Indigenous females aged 35–44. However, these 
rankings are based on a relatively small number of Indigenous deaths (less than 10).  
• The conditions ranked highly for fatal burden were broadly similar for both Indigenous 
and non-Indigenous Australians in all age groups; however there were some differences 
in the top rankings for the 35–64 age groups. While cardiovascular diseases was the 
leading contributor to fatal burden among Indigenous males and females aged 35–54, 
cancer was the leading contributor for non-Indigenous females aged 35–54 and non-
Indigenous males aged 45–54, with injuries the leading contributor for non-Indigenous 
males aged 35–44. Kidney and urinary diseases were ranked fifth for Indigenous females 
aged 55–74, but were not apparent in the top five for non-Indigenous women in this age 
range (see supplementary tables online—tables S3.8 and S3.9).  
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Notes 
1. This figure is based on data in supplementary tables available online—tables S3.2 and S3.3. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.5: YLL for Indigenous Australians, by age, disease group and sex, 2010  
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Notes 
1. This figure is based on data in supplementary tables available online—tables S3.4 and S3.5. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.6: Proportion of YLL for Indigenous Australians, by age, disease group and sex, 2010 
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* Number of Indigenous deaths used in YLL calculations is less than 10.  
Notes 
1. YLL for 2010 is the annual average of 2009–2011.  
2. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.7: Leading causes of fatal burden for Indigenous males, by age group, 2010 
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* Number of Indigenous deaths used in YLL calculations is less than 10. 
Notes 
1. YLL for 2010 is the annual average of 2009–2011.  
2. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.8: Leading causes of fatal burden for Indigenous females, by age group, 2010 
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3.5 Age patterns in YLL for selected disease groups 
This section describes the age patterns in Indigenous YLL results in more detail for selected 
disease groups. Figure 3.9 provides a visual comparison of the fatal burden (YLL) and age-
specific rates (YLL per 1,000 population) by age and sex for these selected disease groups. 
These figures can be used to compare rates of fatal burden between age groups and between 
males and females, or to compare the general shapes of the age patterns among the disease 
groups. The results depend on the number of deaths, the age at death, and, for rates, the sex 
and age-specific population. Note that the scales for number of YLL and rate of YLL vary 
between different disease groups, but are the same for males and females within each disease 
group. 
Some observations from Figure 3.9 include:  
• For some disease groups, Indigenous YLL rates increased consistently with age—for 
example, cardiovascular diseases, and kidney/urinary diseases.  
• For cancer, and for endocrine disorders, YLL rates increased with age to the 65–74 age 
group, after which they declined. 
• While YLL rates were highest in older age groups for most disease groups, the number 
of YLL often peaked in a younger age group. For example, for cardiovascular diseases 
the most YLL occurred in the 45–54 age group for both Indigenous males and females, 
while the rates (YLL per 1,000 population) were highest in the 75 and over age group. 
This is a reflection of the relatively high number of Indigenous deaths in middle age 
from diseases such as cardiovascular diseases (in which the age of onset is often earlier 
than observed in the non-Indigenous population), which gives rise to a greater number 
of YLL due to more years of potential life lost in these age groups compared to the older 
age groups. 
• For injuries, the rate of fatal burden peaked in the 25–34 age group for Indigenous males 
and females. YLL rates for injuries were much higher for Indigenous males than females 
across all age groups except for the 1–14 age group. 
• Infections also showed a different pattern, having the highest YLL rates among 
Indigenous infants aged under 1. 
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Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.9: YLL and age-specific YLL rates (YLL per 1,000 population) for Indigenous Australians for 
selected disease groups, by sex, 2010 
(continued) 
Males Females 
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Notes 
1. This figure is based on data in supplementary tables available online—Tables S3.6 and S3.7.  
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 3.9 (continued): YLL and age-specific YLL rates (YLL per 1,000 population) for Indigenous 
Australians for selected disease groups, by sex, 2010 
Males 
 
Females 
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4 National results: Mortality gap  
Measuring the ‘gap’ in the fatal burden between Indigenous and non-Indigenous Australians 
(commonly referred to as the ‘mortality gap’ hereafter) is of key interest to current policy 
makers, as reflected in the COAG commitment to close the gap in Indigenous life expectancy 
within a generation (COAG 2009).  
Indigenous and non-Indigenous YLL rates presented in this report are based on direct  
age-standardisation and have been adjusted for Indigenous under-identification in mortality 
data. Rate ratios as well as rate differences are presented as measures of the gap in fatal 
burden, as both provide useful information (see ‘Measuring the mortality gap between 
Indigenous and non-Indigenous Australians’ in section 2.4, and Appendixes E and F for 
further information).  
National estimates of the gap in the fatal burden between Indigenous and non-Indigenous 
Australians presented in this chapter include deaths from all Australian states and 
territories. 
Please note that non-Indigenous YLL estimates presented in this chapter are not the same as 
estimates for the total Australian population and should not be used as such. Refer to the 
AIHW report Australian Burden of Disease Study: fatal burden of disease 2010 (AIHW 2015) for 
estimates of fatal burden in the total Australian population.     
4.1 What is the overall gap in fatal burden? 
• In 2010, the total gap (as measured by the YLL rate difference) in fatal burden between 
Indigenous and non-Indigenous Australians was 152 YLL per 1,000 population. The gap 
was greater for males than for females (175 compared to 132 YLL per 1,000 population).  
• The rate of fatal burden experienced by Indigenous Australians was 2.6 times the rate of 
fatal burden experienced by non-Indigenous Australians in 2010. For males, the rate ratio 
was 2.5, and for females, the rate ratio was 2.8 (Table 4.1). 
Table 4.1: Age-standardised YLL rates (per 1,000 population), rate ratios and rate differences, by 
Indigenous status and sex, 2010 
 
Indigenous YLL 
rate 
Non-Indigenous 
YLL rate Rate ratio Rate difference 
Males 291.6 116.2 2.5 175.4 
Females 204.8 72.9 2.8 131.9 
Persons 245.8 93.7 2.6 152.2 
Notes 
1. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E).  
2. Rates are directly age-standardised to the 2001 Australian ERP as at 30 June 2001 (based on the 2001 Census). 
Source: AIHW analysis of the AIHW National Mortality Database. 
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4.2 Which age groups contribute the most to the 
mortality gap? 
Figure 4.1 presents age-specific YLL rates for the Indigenous and non-Indigenous 
populations, as well as rate ratios. This provides a picture of the age groups that have the 
largest absolute disparity in YLL between the two population groups (based on the rate 
difference), as well as the age groups which have the largest relative disparity (based on rate 
ratios).  
• The largest absolute differences in YLL rates between Indigenous and non-Indigenous 
Australians in 2010 were observed for infants (rate difference of 332 per 1,000 
population) and between the ages of 60 and 79, with the greatest difference being in the 
70–74 age group (rate difference of 502 per 1,000). 
• The largest relative differences between Indigenous and non-Indigenous YLL rates were 
observed for those aged 35–39 and 40–44; Indigenous people experienced fatal burden at 
over 4 times the rate of non-Indigenous people in these age groups. 
• This suggests that while YLL rates are much higher in Indigenous populations in the 
middle age groups compared to non-Indigenous populations, the age groups that are 
contributing the most to YLL, and consequently to the absolute gap in YLL, are infants 
and the older age groups (60–79). 
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Notes 
1. This figure is based on data in a supplementary table available online—Table S4.1. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 4.1: Age-specific YLL rates (per 1,000 population) and rate ratios, by Indigenous status and 
age group, 2010 
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4.3 What diseases are the leading contributors to 
the mortality gap? 
In 2010, across all disease groups, Indigenous Australians experienced a higher rate of fatal 
burden than non-Indigenous Australians. The leading disease groups contributing to this 
gap were cardiovascular diseases (responsible for 27% of the gap), cancer and other 
neoplasms (15%), injuries (14%) and endocrine disorders (which includes diabetes) (10%). 
Together, these disease groups accounted for almost two-thirds of the total gap in fatal 
burden of disease and injury (Table 4.2). 
What diseases have the greatest relative disparities between the 
Indigenous and non-Indigenous populations? 
• When looking at rate ratios, the fatal burden caused by endocrine disorders for 
Indigenous Australians was 8 times the rate for non-Indigenous Australians, and the 
fatal burden caused by kidney and urinary diseases was 7 times the non-Indigenous rate. 
While these rate ratios are much higher than for cardiovascular diseases, cancer and 
injuries, their contribution to the total mortality gap was lower (10% for endocrine 
disorders and 6% for kidney and urinary disorders). 
• The diseases that will make the most difference to closing the gap in fatal burden 
between Indigenous and non-Indigenous Australians are cardiovascular diseases, 
cancer, injuries and endocrine disorders (which includes diabetes). Kidney and urinary 
diseases should also be considered as important due to their high relative disparity in 
fatal burden between the Indigenous and non-Indigenous populations.  
Table 4.2: Age-standardised YLL rates (per 1,000 population), rate ratios and rate differences, by 
Indigenous status and disease group, 2010 
Disease group 
YLL per 1,000(a) 
Rate ratio 
Rate 
difference 
Contribution 
to total rate 
difference (%) Indigenous Non-Indigenous 
Cardiovascular  62.0 21.2 2.9 40.8 26.8 
Cancer and other neoplasms 55.8 32.4 1.7 23.4 15.4 
Injuries 33.4 12.6 2.7 20.8 13.7 
Endocrine  17.7 2.2 7.9 15.4 10.1 
Respiratory 16.3 4.5 3.6 11.7 7.7 
Gastrointestinal  15.0 3.5 4.3 11.5 7.6 
Kidney and urinary  10.0 1.5 6.6 8.5 5.6 
Infections 7.0 1.8 3.8 5.1 3.4 
Infant and congenital 8.4 4.5 1.9 3.9 2.5 
Neurological  9.7 5.7 1.7 4.0 2.6 
Mental illnesses and behavioural  4.7 1.5 3.1 3.2 2.1 
Blood and metabolic  3.5 1.2 2.8 2.2 1.5 
Chronic musculoskeletal  1.6 0.6 2.5 1.0 0.6 
Skin  0.7 0.2 3.2 0.5 0.3 
Other disease groups 0.2 0.1 3.0 0.1 0.1 
All diseases 245.8 93.7 2.6 152.2 100.0 
(a) Rates are directly age-standardised to the 2001 Australian ERP as at 30 June 2001 (based on the 2001 Census). 
Note: Number of deaths and YLL for 2010 are the annual average of 2009–2011 and deaths have been adjusted using ABS adjustment factors 
(see Appendix E).  
Source: AIHW analysis of the AIHW National Mortality Database. 
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Notes 
1. This figure is based on data in Table 4.2. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 4.2: YLL rate ratios and rate differences between Indigenous and non-Indigenous 
Australians, by disease group, 2010 
4.4 Do the leading contributors to the mortality gap 
differ by age? 
The contribution of different diseases to the mortality gap between Indigenous and non-
Indigenous Australians varies by age group (Figure 4.3). For example: 
• Infant and congenital conditions, injuries and infections were the greatest contributors to 
the mortality gap among those aged 0–14 in 2010.  
• Injuries was the single largest contributor to the mortality gap among those aged 15–34.  
• Among those aged 35–54, chronic diseases such as cardiovascular diseases and cancer 
start to emerge as important contributors to the mortality gap, as well as gastrointestinal 
diseases, although injuries is still the second largest contributor.  
• Respiratory diseases and endocrine disorders start to become more evident in their 
contribution to the gap among those aged 55–74 and 75 and over. Around 80% of the 
mortality gap was explained by chronic diseases among those aged 55 and over in 2010.  
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Notes 
1. This figure is based on data in a supplementary table available online—Table S4.2. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 4.3: Percentage contribution to the mortality gap (based on YLL rate difference) between 
Indigenous and non-Indigenous Australians, by age and disease group, 2010 
4.5 Do the leading contributors to the mortality gap 
differ by sex? 
• Cardiovascular diseases were the largest contributor to the gap in fatal burden between 
Indigenous and non-Indigenous Australians for both males and females in 2010, 
accounting for 29% and 25% of the gap for males and females respectively (Figure 4.4). 
Indigenous males and females experienced a rate of fatal burden from this disease group 
of around 3 times the rate of non-Indigenous males and females. 
• While the injuries group was ranked as the second leading contributor to the gap for 
males (17%), it was ranked fourth for females (10%), with rate ratios of 2.6 and 2.9 
respectively.  
• Cancer and other neoplasms was ranked second for females and third for males in terms 
of their percentage contribution to the total gap in fatal burden (17% and 14% of the gap 
respectively).  
• Kidney and urinary diseases were responsible for a larger proportion of the gap for 
females than males (7% compared to 4%). This disease group had high Indigenous to 
non-Indigenous rate ratios for both males and females (5.3 and 8.0 respectively), behind 
endocrine disorders which had the highest relative disparities for both males and 
females (rate ratios of 6.7 and 9.6). 
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Notes 
1. This figure is based on data in a supplementary table available online—Table S4.3. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 4.4: Percentage contribution to the mortality gap (based on YLL rate difference) between 
Indigenous and non-Indigenous Australians, by disease group and sex, 2010 
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5 Sub-national results 
This chapter presents estimates of the fatal burden of disease and injury for Indigenous 
Australians for selected states and territories, by remoteness and by level of socioeconomic 
disadvantage. Comparisons to the non-Indigenous population and estimates of the mortality 
gap are also presented where relevant. 
Please note that non-Indigenous YLL estimates presented in this chapter are not the same as 
estimates for the total Australian population and should not be used as such.     
5.1 State/territory 
Indigenous YLL estimates are presented in this section for four states and territories: New 
South Wales, Queensland, Western Australia and the Northern Territory. Indigenous YLL 
estimates are not presented for the other four states and territories due to the small number 
of Indigenous deaths reported for these jurisdictions each year and because individual 
state/territory ABS mortality adjustment factors are not available for Victoria, South 
Australia, Tasmania or the Australian Capital Territory separately (see Appendix E for 
further information). 
What is the overall fatal burden experienced by Indigenous Australians in 
selected states and territories?  
Table 5.1 presents the number of deaths, YLL and age-standardised YLL rates per 1,000 
population in 2010 for Indigenous Australians living in New South Wales, Queensland, 
Western Australia and the Northern Territory. 
Differences in the estimated number of YLL in each state and territory reflect the different 
sizes and age structures of Indigenous populations living in these jurisdictions and 
consequently, the number of deaths reported. Age-standardised YLL rates take both 
population size and age structure into account and are therefore a better measure of state 
and territory differences in fatal burden. 
• In 2010, among the four jurisdictions for which YLL estimates have been calculated, age-
standardised Indigenous YLL rates were the highest in the Northern Territory (349 per 
1,000 population) and Western Australia (319 per 1,000 population), followed by 
Queensland and New South Wales (247 and 233 per 1,000 population respectively). 
Table 5.1: Number of adjusted deaths and YLL, and age-standardised YLL 
rates for Indigenous Australians, NSW, Qld, WA and the NT, 2010 
State/territory Deaths   YLL  
Age-standardised YLL rate 
per 1,000 population 
NSW 920 
 
27,809 232.7 
Qld 785 
 
27,220 246.7 
WA 482 
 
17,183 318.6 
NT 428  16,321 348.5 
Note: Number of deaths and YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted 
using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
 Fatal burden of disease in Aboriginal and Torres Strait Islander people 2010 37 
• The same general pattern in YLL rates by state and territory was evident for Indigenous 
males and females (Figure 5.1).  
 
Notes 
1. This figure is based on data in a supplementary table available online—Table S5.1. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.1: Age-standardised YLL rates for Indigenous Australians, by sex and state/territory (NSW, 
Qld, WA and the NT), 2010 
Are there differences in the main diseases contributing to fatal burden for 
Indigenous Australians by state/territory? 
• In 2010, injuries were the leading cause of fatal burden for Indigenous Australians in 
Queensland, Western Australia and the Northern Territory, contributing 21%, 27% and 
24% of YLL respectively. Cardiovascular diseases were the leading cause of fatal burden 
for Indigenous Australians in New South Wales (contributing 23% of total YLL) (Table 
5.2). 
• Cancer ranked higher and contributed more to Indigenous fatal burden in New South 
Wales (ranked second and contributing 21% of YLL) than in Queensland, Western 
Australia, and the Northern Territory (ranked third and contributing 17%, 16%, and 13% 
respectively).  
• Infant and congenital conditions contributed a larger proportion of the total fatal burden 
for Indigenous Australians in Queensland (14% of YLL) compared to New South Wales, 
Western Australia and the Northern Territory (9%, 6% and 10% of YLL, respectively). 
• Endocrine disorders ranked lower and contributed less to Indigenous fatal burden in 
New South Wales (ranked seventh and contributing 4% of YLL) than in the other 3 
jurisdictions (ranked fifth or sixth and contributing more than 6% of YLL). 
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Table 5.2: Leading causes of fatal burden (YLL) for Indigenous Australians, by state/territory 
(NSW, Qld, WA and the NT) 2010  
 NSW  Qld  WA  NT 
   Rank %  Rank %  Rank %  Rank % 
Injuries     3 19.4  1 21.4  1 27.0  1 23.8 
Cardiovascular diseases     1 22.9  2 19.2  2 20.7  2 21.3 
Cancer and other neoplasms     2 21.1  3 17.0  3 15.6  3 13.3 
Infant and congenital conditions     4 8.8  4 14.2  5 6.4  4 10.4 
Gastrointestinal diseases     5 5.6  6 5.8  4 6.6  6 5.7 
Endocrine disorders     7 3.8  5 6.2  6 6.4  5 6.3 
Respiratory diseases     6 5.1  7 3.6  7 3.8  7 5.0 
Infections    10 3.0  8 3.3  8 3.8  10 2.9 
Kidney and urinary diseases 11(a) 2.1  9 2.8  9 3.5  8 4.7 
Neurological conditions     9 3.0  10 2.0  10 2.6  9 3.0 
(a) Mental and behavioural disorders was ranked 8th in NSW; however is not presented in this table due to the small number of Indigenous 
deaths reported for this disease group for the other three states and territories.  
Note: YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
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Notes  
1. This figure is based on data in Table 5.2. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (See Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.2:  Leading causes of fatal burden (YLL) for Indigenous Australians, by state/territory 
(NSW, Qld, WA and the NT), 2010  
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What is the overall gap in fatal burden between Indigenous and non-Indigenous 
Australians by state/territory? 
• In Western Australia and the Northern Territory, Indigenous Australians experienced 
fatal burden at more than 3 times the rate of non-Indigenous Australians (rate ratios of 
3.6 and 3.1 respectively). The greatest absolute disparity in fatal burden between 
Indigenous and non-Indigenous Australians was in the Northern Territory (rate 
difference of 236 YLL per 1,000 population) (Table 5.3; Figure 5.3).  
• Indigenous Australians in New South Wales and Queensland experienced fatal burden 
at 2.5 times the rate of non-Indigenous Australians.  
Table 5.3: Age-standardised YLL rates (per 1,000 population), rate ratios and rate differences by 
Indigenous status and state/territory (NSW, Qld, WA and the NT), 2010 
  Age-standardised YLL per 1,000 population 
 
Mortality gap 
State/territory Indigenous Non-Indigenous 
 
Rate difference Rate ratio 
NSW 232.7 92.4 
 
140.3 2.5 
Qld 246.7 97.6 
 
149.1 2.5 
WA 318.6 88.5 
 
230.2 3.6 
NT 348.5 112.2  236.3 3.1 
Notes 
1. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E).  
2. Rates are directly age-standardised to the 2001 Australian ERP as at 30 June 2001 (based on the 2001 Census). 
Source: AIHW analysis of the AIHW National Mortality Database. 
 
 
Notes 
1. Data for this figure are in Table 5.3.  
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.3: Age-standardised YLL rates, by Indigenous status and state/territory (NSW, Qld, WA 
and the NT), 2010 
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Are there differences by state/territory in the main disease groups contributing 
to the gap in fatal burden? 
Figure 5.4 shows the top six diseases contributing to the gap in fatal burden between 
Indigenous and non-Indigenous Australians in 2010 for each of the four states and territories 
for which YLL estimates are reported (New South Wales, Queensland, Western Australia 
and the Northern Territory).  
• Cardiovascular diseases and cancer were among the top three disease groups 
contributing to the gap in all four states and territories (although the percentage 
contribution to the gap varied between the states and territories; for example 
cardiovascular diseases contributed 30% of the gap in New South Wales and 25% of the 
gap in the Northern Territory). 
• Injuries were the second leading contributor to the gap in Western Australia (16%), while 
cancer ranked second in New South Wales, Queensland and the Northern Territory. 
• Respiratory diseases ranked higher in New South Wales (fourth) than in the other three 
jurisdictions.  
• Kidney and urinary diseases contributed more to the gap in fatal burden in Western 
Australia and the Northern Territory (ranked sixth and fifth, and contributing 6% and 
8% respectively), than in New South Wales and Queensland. 
Figure 5.5 presents rate differences as well as rate ratios by disease group to provide, 
respectively, a picture of the diseases with the largest absolute differences contributing to the 
gap, and the largest relative disparities. Note that estimates for skin disorders and ‘other 
disease groups’ are not included in Figure 5.5 due to the very small number of Indigenous 
deaths reported for these in each jurisdiction, making the rate ratio estimates for them 
unreliable. 
• In New South Wales, Queensland and Western Australia, Indigenous to non-Indigenous 
rate ratios were highest for endocrine disorders (5.8, 9.9 and 14.0 respectively), while in 
the Northern Territory, kidney and urinary diseases had the highest rate ratio (11.9).
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    NSW Qld WA NT 
R
an
k 
1st Cardiovascular  (30%) Cardiovascular  (26%) Cardiovascular  (26%) 
Cardiovascular  
(25%) 
2nd Cancer  (18%) Cancer  (16%) Injuries (16%) 
Cancer  
(13%) 
3rd Injuries (13%) Endocrine   (12%) 
Cancer  
(15%) Injuries (13%) 
4th Respiratory  (9%) Injuries (12%) 
Endocrine  
 (12%) 
Endocrine  
 (12%) 
5th Endocrine   (7%) 
Gastrointestinal  
(7%) 
Gastrointestinal  
(8%) 
Kidney/urinary  
(8%) 
6th Gastrointestinal (6%) 
Respiratory  
(6%) 
Kidney/urinary  
(6%) 
Respiratory 
(8%) 
Notes 
1. This figure is based on data in a supplementary table available online—Table S5.3. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.4: Leading causes of the gap in fatal burden between Indigenous and non-Indigenous 
Australians (based on YLL rate difference), by state/territory (NSW, Qld, WA and the NT), 2010 
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Note: This figure is based on data in a supplementary table available online—Table S5.3. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.5: YLL rate ratios and rate differences, by disease group and state/territory (NSW, Qld, WA and the NT), 2010 
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5.2 Remoteness  
This section presents Indigenous YLL estimates by remoteness for the five remoteness 
categories Major cities, Inner regional, Outer regional, Remote and Very remote. Unlike results 
presented in other sections of this report, which use ABS mortality adjustment factors, these 
estimates have been adjusted using AIHW adjustment factors.  
AIHW adjustment factors have been used as there are a number of limitations with the ABS 
remoteness adjustment factors. As discussed in Chapter 2, the ABS remoteness adjustment 
factors are only available for the two combined remoteness categories Major cities/Inner 
regional combined and Outer regional/Remote/Very remote combined. These combined 
remoteness categories are not considered the most useful to policymakers for examining 
mortality disparities by remoteness, given the wide variation between the five remoteness 
categories, and because the chosen groupings of remoteness (in particular, the combining of 
Outer regional with Remote and Very remote) mask any mortality disparities by remoteness—
they do not follow the typical categories of non-remote and remote. Furthermore, Indigenous 
YLL estimates based on the ABS adjustment factors for these two grouped remoteness 
categories were very similar, which is somewhat counter intuitive given the known higher 
rates of Indigenous mortality in remote areas, raising further questions about their 
usefulness.  
It is important to note that YLL estimates by remoteness presented in this section of the 
report are not comparable to YLL estimates presented in the rest of this report, as the two 
sets of estimates are based on differing adjustment factors as outlined above. Total numbers 
of adjusted deaths and YLL should be sourced from tables for national results, which are 
based on the ABS adjustment factors.  
For more information on the remoteness adjustment factors applied, see Appendix E. 
What is the overall fatal burden experienced by Indigenous Australians in each 
remoteness area?  
• In 2010, the highest number of Indigenous deaths and YLL were in in Major cities and the 
lowest number of deaths and YLL were in Remote areas (Table 5.4). 
• When examining age-standardised YLL rates, Remote areas had the highest rate of fatal 
burden in the Indigenous population (339 YLL per 1,000 population), followed by Very 
remote areas (293 YLL per 1,000 population) (Figure 5.6).  
Table 5.4: Number of adjusted deaths and YLL for Indigenous Australians, 
by remoteness, 2010 
Remoteness   Deaths YLL Age-standardised YLL rate 
Major cities  775 25,248 194.7 
Inner regional  463 14,792 180.5 
Outer regional  651 21,718 242.0 
Remote  348 12,157 338.6 
Very remote   503 18,900 292.8 
Note: Number of deaths and YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted 
using AIHW remoteness adjustment factors (see Appendix E). As a result, estimates by remoteness will not 
match other estimates in this report which have been adjusted using ABS adjustment factors.  
Source: AIHW analysis of the AIHW National Mortality Database. 
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Notes 
1. This figure is based on data in Table 5.4. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using AIHW remoteness adjustment factors (see Appendix E). 
As a result, estimates by remoteness will not match other estimates in this report which have been adjusted using ABS adjustment factors. 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.6: Age-standardised YLL rates for Indigenous Australians, by remoteness, 2010 
Are there differences by remoteness in the main disease groups contributing 
to fatal burden for Indigenous Australians? 
• In 2010, injuries, cardiovascular diseases and cancer were among the biggest 3 
contributors to fatal burden among Indigenous Australians in all five remoteness 
categories; however there were some minor differences in the rankings and percentage 
contributions to total YLL. For example, injuries was the leading contributor to fatal 
burden in Major cities and Remote and Very remote regions, while it ranked second to 
cardiovascular diseases in Inner regional and Outer regional areas (Figure 5.7).  
• Infant and congenital conditions was the fourth largest contributor to fatal burden 
among Indigenous Australians in all remoteness categories except for Remote areas, 
where it was ranked fifth and representing 7% of total YLL, slightly less than endocrine 
disorders (also 7%).  
• Kidney and urinary diseases was a larger contributor to Indigenous YLL in Remote and 
Very remote areas (ranked 7th and 8th respectively, and representing 5% of total YLL) 
compared to Major cities (ranked 12th and representing 2% of total YLL).  
• Gastrointestinal diseases were ranked higher and contributed to a greater proportion of 
Indigenous YLL in non-remote areas than in remote areas. 
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Notes 
1. This figure is based on data in supplementary table online—Table S5.4. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using AIHW remoteness adjustment factors (see Appendix 
E). As a result, estimates by remoteness will not match other estimates in this report which have been adjusted using ABS adjustment 
factors. 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.7: Leading causes of fatal burden (YLL) for Indigenous Australians, by remoteness, 2010  
What is the overall gap in YLL between Indigenous and non-Indigenous 
Australians by remoteness area? 
• When examining age-standardised YLL rates for the five remoteness categories, the 
greatest disparity between Indigenous and non-Indigenous Australians was in Remote 
areas (rate difference of 236 YLL per 1,000 population; rate ratio of 3.3), followed by Very 
remote areas (rate difference of 185 per 1,000 population; rate ratio of 2.7) (Table 5.5). 
• The gap between Indigenous and non-Indigenous Australians was lowest in Inner 
regional areas (rate difference of 77 YLL per 1,000 population; rate ratio of 1.7) (Table 5.5).  
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Table 5.5: Age-standardised YLL rates (per 1,000 population), rate ratios and  
rate differences, by Indigenous status and remoteness, 2010 
  YLL per 1,000       
Remoteness Indigenous Non-Indigenous   Rate ratio Rate difference 
Major cities 194.7 88.3 
 
2.2 106.4 
Inner regional 180.5 103.4 
 
1.7 77.1 
Outer regional 242.0 107.6 
 
2.2 134.4 
Remote 338.6 102.8 
 
3.3 235.8 
Very remote 292.8 107.5  2.7 185.3 
Notes 
1. Rates are directly age-standardised to the 2001 Australian ERP as at 30 June 2001 (based on the 2001 
Census). 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using AIHW remoteness 
adjustment factors (see Appendix E). As a result, estimates by remoteness will not match other estimates 
in this report which have been adjusted using ABS adjustment factors. 
Source: AIHW analysis of the AIHW National Mortality Database. 
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Notes 
1. This figure is based on data in Table 5.5. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using AIHW remoteness adjustment factors (see Appendix 
E). As a result, estimates by remoteness will not match other estimates in this report which were adjusted using ABS adjustment factors. 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.8: Age-standardised YLL rates and rate ratios, by Indigenous status and remoteness, 2010 
Are there differences by remoteness in the main disease groups contributing 
to the gap in fatal burden? 
Figure 5.9 shows the top six disease groups contributing to the gap in fatal burden between 
Indigenous and non-Indigenous Australians in 2010 in each of the five remoteness 
categories.  
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• Cardiovascular diseases were the biggest contributor to the gap in all five remoteness 
categories (24% of the total rate difference in Remote areas to 37% of the total rate 
difference in Inner regional areas). 
• Injuries were the second leading contributor to the gap in Remote areas (17%) and third 
in Major cities (17%) and Very remote areas (13%); however injuries ranked sixth in Inner 
regional areas (7% of the gap). 
• Kidney and urinary diseases featured in the top five disease groups contributing to the 
gap in Remote and Very remote areas (ranked fifth, and contributing 8% and 9% of the 
YLL rate difference, respectively). 
• Gastrointestinal diseases ranked higher and contributed to a greater proportion of the 
gap in YLL in non-remote areas than in remote areas. 
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Notes 
1. This figure is based on data in a supplementary table available online—Table S5.5. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using AIHW remoteness adjustment factors (see Appendix 
E). As a result, estimates by remoteness will not match other estimates in this report which were adjusted using ABS adjustment factors. 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.9: Leading causes contributing to the gap in fatal burden between Indigenous and non-
Indigenous Australians (based on YLL rate difference), by disease group and remoteness, 2010
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Figure 5.10 presents two measures of the gap—rate differences and rate ratios—by disease 
group, to provide a picture of the diseases with the largest absolute disparities in fatal 
burden between the Indigenous and non-Indigenous populations (based on rate differences) 
and the disease groups with the largest relative disparities (based on rate ratios).  
• The largest rate ratio in Major cities was for endocrine disorders (4.8). Endocrine 
disorders also had high rate ratios in the other remoteness categories. In Remote and Very 
remote areas, kidney and urinary diseases had the highest rate ratio (14.9 in Remote and 
9.5 in Very remote).   
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Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.10: YLL rate ratios and rate differences, by disease group and remoteness, 2010 
(continued) 
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Notes 
1. This figure is based on data in a supplementary table available online—Table S5.5. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using AIHW remoteness adjustment factors (see Appendix    
E). As a result, estimates by remoteness will not match other estimates in this report which were adjusted using ABS adjustment factors. 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.10 (continued): YLL rate ratios and rate differences, by disease group and remoteness, 2010 
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5.3 Socioeconomic disadvantage 
This section presents the number and crude rate of YLL for the Indigenous population by 
Indigenous Relative Socioeconomic Outcomes (IRSEO) index quintile (Biddle 2009; Biddle 
2013). This is an Indigenous-specific index of socioeconomic disadvantage, developed by  
Dr Nicholas Biddle of the Centre for Aboriginal Economic Policy Research (CAEPR), which 
reflects the level of socioeconomic disadvantage experienced by Indigenous Australians 
living in each Indigenous Area in Australia. The 1st quintile is the most disadvantaged and 
the 5th quintile is the least disadvantaged.  
Crude YLL rates for the non-Indigenous population are also presented in this section using a 
rescaled Pooled Non-Indigenous Relative Socioeconomic Outcomes index (PNIRSEO) 
(Biddle 2013), which uses a ranking for the socioeconomic disadvantage of non-Indigenous 
Australians living in each area. While not directly comparable to the IRSEO Index, it enables 
an examination of differences in the general pattern and variation by socioeconomic 
disadvantage in the fatal burden of disease for the two population groups. 
Further information on socioeconomic disadvantage indexes available, and those used in this 
report, can be found in Appendix C. 
What is the overall fatal burden experienced by Indigenous Australians in each 
quintile of socioeconomic disadvantage? 
Table 5.6 shows the number of deaths, number of YLL and the percentage of total 
Indigenous YLL observed in 2010 by socioeconomic disadvantage quintile (based on the 
IRSEO index). As the ISREO index quintiles are based on the number of regions, rather than 
the number of individuals within each region, differences in the number of deaths and YLL 
in each quintile may reflect differences in the size of the population within each quintile.  
Table 5.6: Number of adjusted deaths and YLL for Indigenous Australians, by socioeconomic 
disadvantage quintile (IRSEO index), 2010 
  
Socioeconomic disadvantage 
quintile (IRSEO index) 
    YLL 
Deaths   Number % of total Indig. YLL(a) 
Crude YLL rate per 
1,000 population 
1st (Most disadvantaged)  624  
 
 22,723  23.7 261.2 
2nd  558  
 
 18,402  19.2 181.7 
3rd  760  
 
 24,679  25.7 139.1 
4th  557  
 
 18,310  19.1 105.1 
5th (Least disadvantaged)  387  
 
 11,625  12.1 90.6 
(a) Excluding deaths with unknown IRSEO quintile. 
Note: Number of deaths and YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see 
Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database.50 
When examining crude YLL rates per 1,000 Indigenous population, a consistent gradient was 
observed by socioeconomic disadvantage quintile (Figure 5.11). Indigenous people living in 
areas with the most socioeconomic disadvantage experienced the highest rate of YLL (261 
per 1,000 population) and those in areas with the least socioeconomic disadvantage 
experienced the lowest rate of YLL (91 per 1,000 population). 
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Notes  
1. ERP by Indigenous status and SA2 are only available in Census years. As a result the rates are calculated using 2011 Indigenous ERP at 
SA2 level. 
2. This figure is based on data in Table 5.6. 
3. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.11: Crude YLL rates (per 1,000 population) for Indigenous Australians, by socioeconomic 
disadvantage quintile (IRSEO index), 2010 
Are there differences by socioeconomic disadvantage in the main disease 
groups contributing to fatal burden for Indigenous Australians? 
• In 2010, injuries, cardiovascular diseases and cancer were among the top three 
contributors to fatal burden among Indigenous Australians in each socioeconomic 
disadvantage quintile. There were some minor differences, however, in the ranking and 
percentage contribution to Indigenous YLL (Figure 5.12; Table 5.7). For example, cancer 
contributed a larger proportion of YLL for Indigenous Australians living in the least 
socioeconomically disadvantaged quintile (20%) compared to the most disadvantaged 
quintile (14%), and cardiovascular diseases contributed a larger proportion of YLL in the 
two most disadvantaged quintiles (4th and 5th). 
• Endocrine disorders ranked higher and contributed a larger proportion of YLL for 
Indigenous Australians living in the most disadvantaged quintile (ranked 5th and 
contributing 6% of YLL), compared to the least disadvantaged quintile (ranked 7th and 
contributing 4% of YLL). 
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Notes 
1. This figure is based on data in Table 5.7 and a supplementary table available online—Table S5.8. 
2. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.12: Proportion of disease groups contributing to YLL for Indigenous Australians, by 
socioeconomic disadvantage quintile (IRSEO index), 2010  
Table 5.7: Ranking and percentage contribution of leading disease groups to total YLL, by 
socioeconomic disadvantage quintile (IRSEO index), 2010  
 
1st  
(Most dis-
advantaged)  2nd  3rd  4th  
5th  
(Least  dis-
advantaged) 
 Disease group Rank %  Rank %  Rank %  Rank %  Rank % 
Injuries  1  24.6    2  20.4    2  20.0    1  22.0    1  25.6  
Cardiovascular 
diseases 
 2  21.9    1  23.9    1  20.9    2  19.3    3  18.8  
Cancer and other 
neoplasms 
 3  14.3    3  17.3    3  17.6    3  19.2    2  19.6  
Infant and congenital 
conditions 
 4  9.7    4  8.3    4  10.2    4  12.8    4  9.2  
Gastrointestinal 
diseases 
 7  4.7    5  7.1    5  6.5    5  6.4    5  6.4  
Endocrine disorders  5  6.3    6  5.3    6  5.9    6  4.4    7  3.5  
Respiratory diseases  6  5.2    7  4.6    7  4.4    7  3.8    6  4.8  
Infections  9  3.3    8  3.4    8  3.4    9  2.9    10  2.9  
Kidney and urinary 
diseases 
 8  3.9    9  3.2    9  3.2    10  2.3    (b)  1.5  
Neurological 
conditions 
 10  2.2    10  2.8    (a)  2.8    8  3.0    8  3.0  
(a) Neurological conditions fell outside the top 10 leading causes in the 3rd quintile as Mental and behavioural disorders ranked 10th. 
(b) Kidney and urinary diseases fell outside the top 10 leading causes in the 5th quintile as Mental and behavioural disorders was ranked 9th.   
Note: YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
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How does the pattern in fatal burden by socioeconomic disadvantage for the 
Indigenous population compare to that observed for the non-Indigenous 
population? 
Figure 5.13 presents crude YLL rates for non-Indigenous Australians by socioeconomic 
disadvantage quintile based on the rescaled PNIRSEO index.  
• In 2010, the highest YLL rates were observed for non-Indigenous persons living in the 
most socioeconomically disadvantaged areas (130 YLL per 1,000 population) and the 
lowest YLL rates were observed for non-Indigenous persons living in the least 
disadvantaged areas (80 YLL per 1,000 population) (Figure 5.13). 
• While not directly comparable to Indigenous YLL rates based on the IRSEO index due to 
the different indexes used, examination of YLL rates by socioeconomic disadvantage for 
the non-Indigenous population (based on the PNIRSEO index) show the same general 
pattern as seen in the Indigenous population (increasing rates of YLL with increasing 
level of disadvantage). However the gradient by socioeconomic disadvantage was not as 
steep as seen in the Indigenous population. 
 
 
Notes 
1. ERP by Indigenous status and SA2 are only available in Census years. As a result the rates are calculated using 2011 non-Indigenous ERP 
at SA2 level.  
2. This figure is based on data in a supplementary table available online—Table S5.9. 
3. YLL for 2010 is the annual average of 2009–2011. Deaths have been adjusted using ABS adjustment factors (see Appendix E). 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure 5.13: Crude YLL rates for non-Indigenous Australians, by socioeconomic disadvantage 
quintile (PNIRSEO index), 2010 
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6 International comparisons  
International comparisons are important in order to benchmark Australia against countries 
that share similar health goals and face similar challenges, such as those relating to the health 
needs of indigenous populations.  
Burden of disease estimates are available for the Māori population of New Zealand from the 
recent New Zealand Burden of Diseases, Injuries and Risk Factors Study, 2006–2016 (NZBD) 
which is described below. This chapter presents high level comparisons of YLL estimates for 
the Aboriginal and Torres Strait Islander population compared to the Māori population, as 
well as comparisons of the mortality gap (differences in rates of fatal burden) between the 
indigenous and non-indigenous populations in the two countries. Methodological 
differences between the ABDS and the New Zealand study should be taken into 
consideration when interpreting the results presented in this chapter (for further details see 
‘Comparability between the ABDS and NZBD’ in section 6.1 below). 
6.1 New Zealand Burden of Diseases, Injuries and 
Risk Factors Study, 2006–2016 
The NZBD included burden of disease estimates (including YLL estimates) for both major 
ethnic groups (Māori and non-Māori) in New Zealand. Apart from the previous and current 
Indigenous Australian burden of disease studies, this is the only national study to have 
produced estimates for an indigenous population. Estimates for the Māori population (and 
estimates of the gap between Māori and non-Māori) can therefore potentially be used for 
international comparisons with estimates produced for the Aboriginal and Torres Strait 
Islander population in Australia.  
While Māori make up a much greater proportion of the total New Zealand population (15% 
in 2013) compared to the proportion of the Indigenous population in Australia (3% in 2011), 
the age structures of the two populations are quite similar. For example, just over one-third 
of the Indigenous Australian and Māori populations are aged under 15 (36.5% and 34.5%, 
respectively), whereas only 3.3% of the Indigenous Australian population and 4.1% of the 
Māori population are aged 65 or over.  
Comparability between the ABDS and NZBD 
The ABDS and NZBD studies have similarities in methodologies used for estimating YLL. 
For example, both studies use the same standard life table, use a single high quality data 
source for mortality data, and do not use age-weighting or discounting. There are differences 
in cause lists, reporting periods and redistribution methods used, but these differences are 
unlikely to affect broad comparisons between the ABDS and NZBD results presented here 
(see below for more details). 
One methodological difference between the two studies that could affect comparability of 
the results is the standard population used to directly age-standardise YLL rates to allow for 
comparability between indigenous and non-indigenous populations. The standard 
population used for the ABDS is the Australian population at 30 June 2001 (based on the 
2001 Census), whereas the standard population used for NZBD was the WHO World 
Population. To increase the comparability of results between the ABDS and NZBD in this 
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section, YLL rates for Australia have been recalculated using the WHO World Population as 
the standard population.  
Table 6.1 provides a comparison of the key methodological approaches for the ABDS and 
NZBD for the calculation of YLL estimates. 
Table 6.1: Comparison of key methodological differences for YLL estimates between the ABDS and 
NZBD  
Component 
ABDS (Aboriginal and Torres Strait 
Islander estimates) NZBD (Māori estimates) 
Cause list 195 diseases grouped into 17 broad 
disease groups 
217 diseases and injuries grouped into 16 
broad disease groups  
Standard life table GBD 2010(a) GBD 2010(a) 
Age groups 16 age groups  
(0–4, 5–9,…70–74, 75+ years) 
19 age groups  
(0–1,1–4,5–9,…80–84, 85+ years) 
Data sources(b) Single source— AIHW’s National Mortality 
Database 
Single source—New Zealand Mortality 
collection 
Standard population (for 
ethnicity group comparisons)(c) 
2001 total Australian population (based on 
2001 Census ERP) (c) WHO World Population 
Discounting None None 
Age weighting None None 
Period reported 2010 2006 
Time period for mortality data 
analyses 2009–2011 2005–2007 
(a) Aspirational life table developed as part of the GBD 2010 study. 
(b) By international standards both Australia and New Zealand are regarded as having high-quality systems of death registration, with relatively 
few deaths coded to problematic underlying causes of death. 
(c) For this section of the report, to increase comparability with the NZBD, YLL rates for Australia have been recalculated using the WHO World 
Population as the standard population. 
Cause list 
The ABDS and NZBD have similar, but not identical, lists of conditions and sequelae, and 
the case definitions sometimes differ. The disease groups do not always include the same list 
of causes and in some circumstances, different ICD-10 codes are used to count causes of 
death. Differences in ICD code allocation creates potential differences between studies, but 
those variations mostly impact at the cause level rather than disease group level so have less 
impact on the results presented in this chapter. However, there are some coding differences 
that do impact at the disease group level. An example is chronic viral hepatitis C, which is 
included in the Infections disease group in NZBD, but is included in the Gastrointestinal diseases 
group in the ABDS. 
A corresponding NZBD disease group can be identified for 16 of the 17 broad condition 
groups used in the ABDS (see Table 6.2). The main difference is the inclusion of a separate 
disease group Blood and metabolic disorders in the Australian Study. In NZBD the disease 
group Diabetes and other endocrine disorders included metabolic disorders, and Vascular and 
blood disorders included blood disorders. Only a small number of total YLL are attributed to 
the Blood and metabolic disorders disease group for Indigenous Australians in the ABDS (1.3% 
of total YLL, see Table 3.2). Comparatively, a much larger number of YLL are attributed to 
‘Cardiovascular diseases’ and ‘Endocrine disorders’ (21.0% and 5.4% of total YLL for 
Indigenous Australians, respectively). Hence, the decision was made to exclude the ABDS 
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disease group ‘Blood and metabolic disorders’ from the comparison analysis in this chapter. 
The ABDS disease groups Cardiovascular diseases and Endocrine disorders were deemed 
comparable to the NZBD disease groups Vascular and blood disorders and Diabetes and other 
endocrine disorders.  
As the ABDS disease group Blood and metabolic disorders only accounts for a small number of 
YLL (3.5 YLL per 1,000 population, see Table 4.2), the impact of excluding this disease group 
from the analyses is likely to be minimal. When Blood and metabolic disorders was included in 
the ABDS rankings for YLL rates per 1,000 population at the preliminary analyses stage for 
this chapter it ranked 12th for Indigenous Australian males and 11th for Indigenous 
Australian females. 
Table 6.2: Broad disease group comparison for the ABDS and NZBD 
ABDS broad disease groups   NZBD broad condition groups 
Cancer and other neoplasms   Cancers and other neoplasms 
Cardiovascular diseases   Vascular and blood disorders 
Chronic musculoskeletal disorders   Musculoskeletal disorders 
Respiratory diseases   Respiratory disorders 
Endocrine disorders   Diabetes and other endocrine disorders 
Gastrointestinal diseases   Gastrointestinal disorders 
Infant and congenital conditions   Infant conditions and birth defects 
Infections   Infections 
Injuries   Injury 
Kidney and urinary diseases   Genitourinary disorders 
Mental illnesses and behavioural disorders   Mental disorders 
Neurological conditions   Neurological conditions 
Oral disorders   Dental disorders 
Reproductive and maternal conditions   Reproductive and gestational disorders 
Sense organ disorders   Sense organ disorders 
Skin disorders   Skin disorders 
Blood and metabolic disorders   . . 
Reporting periods 
The ABDS and NZBD have different reporting periods: 2010 for the ABDS (based on 
analyses of data from 2009–2011) and 2006 for NZBD (based on data from 2005–2007). This 
difference in reporting periods is expected to have minimal impact on the international 
comparisons made in this chapter. 
Redistribution methods 
The ABDS uses a similar approach for redistribution to other burden of disease studies, but 
the algorithms or exact specifications for the reassignment are different (see Appendix D). 
Three methods for redistribution of Indigenous and total Australian deaths were used in the 
ABDS; the application of redistribution algorithms based on direct evidence, indirect 
multiple cause of death analysis, and proportionate allocation within age-by-sex strata. 
Using the Australian cause list, approximately 10% of total Australian deaths, 8% of total 
YLL and about 8% of Indigenous deaths were identified for redistribution. 
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The NZBD used three different types of redistribution algorithms for both the Māori and 
non-Māori populations; simple proportionate redistribution within age-by-sex strata, 
statistical modelling and expert judgement. In all, 10.4% of deaths (7.1% of YLL) were 
redistributed in NZBD (MOH 2012).  
Although it is not possible to quantify the exact impact of the different redistribution 
methods used by the two studies, the NZBD redistribution proportions (10% of deaths, 7% of 
YLL) are very similar to those in the ABDS (10% of deaths, 8% of YLL).  
6.2 Results 
Total YLL and rate difference (gap measure) 
When directly age-standardised to the WHO World Population, the total YLL per 1,000 
population were slightly higher for Aboriginal and Torres Strait Islander males and females 
(243 and 166 per 1,000 respectively) than for Māori males and females (223 and 148 per 1,000 
respectively) (Table 6.3).  
The gap (measured as the rate difference between the indigenous and non-indigenous 
populations in each country) was also higher for males and females in Australia than in New 
Zealand (rate difference for males of 151 compared to 119, and for females of 110 compared 
to 82, in Australia and New Zealand respectively). 
For both countries, indigenous YLL rates and rate differences were higher for males than for 
females. 
Table 6.3: Age-standardised YLL rates (per 1,000), rate ratios and rate differences, for the Australian 
Aboriginal and Torres Strait Islander population (2010) and New Zealand Māori (2006)(a)(b)  
 
Males  Females 
 Indigenous YLL per 1,000(a) 
Rate 
ratio 
Rate 
difference  
Indigenous YLL 
per 1,000(a) 
Rate 
ratio 
Rate 
difference 
Australia Indigenous 242.5 2.6 150.9  165.9 2.9 109.6 
New Zealand Māori 222.6 2.2 119.3  148.1 2.2  82.3 
(a) Rates directly age-standardised to the WHO World Population. 
(b) Analyses for Indigenous Australians based on 2009–2011 mortality data and adjusted deaths using ABS adjustment factors. 
Source: AIHW analysis of the AIHW National Mortality Database; AIHW analysis of NZBD results. 
Broad disease groups 
Rankings 
Figures 4.1 and 4.2 compare the rankings of the 16 broad disease groups by fatal burden for 
Indigenous Australians and Māori by sex. Different colours are used to represent disease 
rankings within each country; for example, the lightest colour indicates the five disease 
groups with the highest YLL rate per 1,000 population. The numbers indicate the rank (based 
on YLL rate) of that disease group in each country.  
Overall, there was reasonable agreement between the rankings of disease groups by their 
contribution to the fatal burden for Indigenous Australians and Māori. Cardiovascular 
diseases, cancer and injuries were the top three contributors to the fatal burden for 
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Indigenous males and females in both Australia and New Zealand. And the lowest six of the 
16 contributing disease groups were the same in Australia and New Zealand for both males 
and females. 
The largest disparities between the Indigenous Australian and Māori YLL rankings were for 
gastrointestinal diseases, infant and congenital conditions and infections. Gastrointestinal 
diseases ranked higher for Indigenous Australian males and females (4th and 6th, 
respectively) than for Māori males and females (9th and 10th, respectively). Comparatively, 
infant and congenital conditions and infections ranked lower for Indigenous Australian 
males and females (7th and 9th/10th) than for Māori males and females (4th and 7th) 
(figures 6.1 and 6.2).  
  
Males 
Australia Indigenous New Zealand Māori  
Cardiovascular diseases(a) 1 1 
Injuries 2 3 
Cancer and other neoplasms 3 2 
Gastrointestinal diseases 4 9 
Endocrine disorders(a) 5 5 
Respiratory diseases 6 6 
Infant and congenital conditions 7 4 
Neurological conditions 8 10 
Infections 9 7 
Kidney and urinary diseases 10 8 
Mental illnesses and behavioural disorders 11 11 
Chronic musculoskeletal disorders 12 12 
Skin disorders 13 13 
Oral disorders 14 14 
Maternal and reproductive conditions 15 16 
Sense organ disorders 16 15 
 
Ranking scale   Top 5   6–10   11–16 
 
(a) In the NZBD, 'Endocrine disorders' include metabolic disorders, and 'Cardiovascular diseases' include blood disorders. In the ABDS there 
was a separate broad disease group for 'Blood and metabolic disorders' that has been excluded from this comparison analysis. For 
Indigenous Australian males, 'Blood and metabolic disorders' accounted for a small number of YLL (4.2 YLL per 1,000 population) and a 
small proportion of the total gap (1.6%) (see supplementary table available online—Table S4.3). 
Note: This figure is based on data in a supplementary table available online—Table S6.1. 
Source: AIHW analysis of the AIHW National Mortality Database; AIHW analysis of NZBD results. 
Figure 6.1: Ranking of broad disease groups by YLL for Indigenous Australian (2010) and Māori 
males (2006)  
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Females 
Australia Indigenous New Zealand Māori  
Cancer and other neoplasms 1 1 
Cardiovascular diseases(a) 2 2 
Injuries 3 3 
Endocrine disorders(a) 4 6 
Respiratory diseases 5 5 
Gastrointestinal diseases 6 10 
Infant and congenital conditions 7 4 
Kidney and urinary diseases 8 8 
Neurological conditions 9 9 
Infections 10 7 
Mental illnesses and behavioural 
disorders 11 13 
Chronic musculoskeletal disorders 12 11 
Skin disorders 13 15 
Reproductive and maternal conditions 14 12 
Sense organ disorders 15 14 
Oral disorders 16 16 
 
Ranking scale   Top 5   6–10   11–16 
(a) In the NZBD 'Endocrine disorders' include metabolic disorders and 'Cardiovascular diseases' include blood disorders. In the ABDS there was 
a separate broad disease group for 'Blood and metabolic disorders' which has been excluded from this comparison analysis. For Indigenous 
Australian females, 'Blood and metabolic disorders' accounted for a small number of YLL (2.9 YLL per 1,000 population) and a small 
proportion of the total gap (1.4%) (see supplementary table available online—Table S4.3). 
Note: This figure is based on data in a supplementary table available online—Table S6.2. 
Source: AIHW analysis of the AIHW National Mortality Database; AIHW analysis of NZBD results. 
Figure 6.2: Ranking of broad disease groups by YLL for Indigenous Australian (2010) and Māori 
females (2006)  
Contribution to total gap 
Figure 6.3 presents the percentage contributions of each disease group to the gap in fatal 
burden (based on the YLL rate difference) between Indigenous and non-Indigenous 
Australians compared to the gap between Māori and non-Māori in New Zealand.  
• Cardiovascular diseases, cancer and injuries were the top three contributors to the gap in 
fatal burden for males and females in both Australia and New Zealand. These three 
disease groups accounted for over half the total YLL gap between Indigenous and  
non-Indigenous Australian males and females ((60% and 53% respectively), and over 
two-thirds of the total YLL gap between Māori and non-Māori males and females (72% 
and 69% respectively). 
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Notes 
1. In the NZBD the equivalent ‘Endocrine disorders' condition group (‘Diabetes and other endocrine disorders’) included metabolic disorders 
and the equivalent 'Cardiovascular diseases' condition group (‘Vascular and blood disorders’) included blood disorders. In the ABDS there 
was a separate broad disease group for 'Blood and metabolic disorders' which has been excluded from this comparison analysis. For 
Indigenous Australian males and females 'Blood and metabolic disorders' accounted for a small number of YLL (4.2 and 2.9 YLL per 1,000 
population, respectively) and a small proportion of the total gap (1.6% and 1.4%, respectively) (see supplementary table available online—
Table S4.3).  
2. Rates directly age-standardised to the WHO World Population.  
3. This figure is based on data in supplementary tables available online—tables S6.1 and S6.2. 
Source: AIHW analysis of the AIHW National Mortality Database; AIHW analysis of NZBD results. 
Figure 6.3: Percentage contributions to the gap (based on YLL rate difference), by disease group and 
sex, Australia Indigenous:non-Indigenous (2010) and New Zealand Māori: non-Māori (2006)  
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7 Discussion 
This report provides estimates of fatal burden among the Aboriginal and Torres Strait 
Islander population in Australia at the disease group level. Estimates of the gap in fatal 
burden between Indigenous and non-Indigenous Australians are also presented, as well as 
estimates for selected state/territories, remoteness and socioeconomic disadvantage where 
valid.  
In recent decades improvements have been made to both the quality and availability of data 
on the health of Indigenous Australians. However, a number of limitations need to be 
considered when interpreting the results of this report. Firstly, national data linkage studies 
have provided adjustment factors that can be used to correct for under-identification of 
Indigenous status in death registrations. While using these factors improves the accuracy of 
YLL estimates presented in this report, uncertainty still exists around the true level of 
mortality among Indigenous Australians. A long-term strategy to improve Indigenous 
mortality estimates is through improvements to the data at the collection phase so that fewer 
adjustments will be necessary for Indigenous mortality reporting in the future. 
A second limitation is that the Indigenous population is very small relative to the non-
Indigenous population, accounting for 3% of the total Australian population. Small numbers 
in either the population or deaths data can affect the reliability of results, particularly when 
data are compared across disease groups, age groups or jurisdictions. 
Two key methodological issues in producing estimates of fatal burden for the Indigenous 
population were therefore to determine the most suitable approach for adjusting deaths for 
Indigenous under-identification in mortality data, and assessing the number of years of 
mortality data to combine to produce robust YLL estimates to overcome small numbers.  
In addition, a number of other methodological considerations specific to Indigenous 
estimates were examined. These included deciding on the best means of measuring the 
mortality gap between Indigenous and non-Indigenous Australians (including considering 
the benefits of using either direct or indirect age-standardisation, and rate differences 
compared to rate ratios); determining the most appropriate measure of socioeconomic 
disadvantage for the Indigenous population, and assessing the impact of using different 
standard life tables on resulting Indigenous YLL estimates. In consultation with the 
Indigenous Reference Group (IRG), a significant amount of work was undertaken to test the 
sensitivity of results to differing methodological choices.  
As a result, AIHW authors and the IRG agreed to: 
• Adopt the GBD 2010 standard life table for calculation of Indigenous YLL. While using 
this life table results in a greater YLL for Indigenous Australians than using life tables 
with a lower life expectancy (as used in previous burden of disease studies), sensitivity 
analyses shows no difference in the ranking of diseases in terms of both Indigenous YLL 
and the ‘gap’ in fatal burden.  
• Aggregate three years of mortality data, and combine age groups and disease groups 
where needed in order to overcome issues with small numbers and improve the 
reliability of the estimates. 
• Apply ABS mortality adjustment factors to correct Indigenous under-identification in 
mortality data, with the exception of estimates by remoteness, for which AIHW 
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adjustment factors were used due to limitations with the available ABS remoteness 
adjustment factors. 
• Report state/territory results for New South Wales, Queensland, Western Australia and 
the Northern Territory only. Indigenous YLL estimates are not presented for Victoria, 
South Australia, Tasmania or the Australian Capital Territory due to the small number 
of Indigenous deaths reported for these jurisdictions, and because individual 
state/territory adjustment factors are not available from the ABS for these states and 
territories. 
• Use direct age-standardisation to calculate YLL rates for comparing the Indigenous and 
non-Indigenous populations. 
• Use YLL rate differences as the primary measure of the gap in fatal burden, and rate 
ratios as a secondary measure where appropriate. 
• Use the Indigenous Relative Socioeconomic Outcomes (IRSEO) index to examine 
variation in the fatal burden of disease for the Indigenous population by level of 
socioeconomic disadvantage. 
Key findings and policy implications 
A considerable component of the fatal burden in the Aboriginal and Torres Strait Islander 
population is experienced in infancy (12% of total YLL for males and 11% for females) and in 
middle age. This reflects the relatively high number of deaths occurring in these age groups, 
as well as a larger number of potential years of life lost per individual compared to deaths 
occurring in the older age groups. 
Injuries and cardiovascular diseases were the leading causes of fatal burden among the 
Indigenous population in 2010 (22% and 21% of total YLL respectively), followed by cancer 
(17%). Injuries ranked ahead of cardiovascular diseases and cancer, despite having a lower 
number of deaths. The higher burden from injuries relative to the proportion of deaths is 
primarily due to Indigenous people dying (on average) at younger ages from injuries than 
from cardiovascular diseases or cancer and therefore having more years of life lost (injuries 
were the leading cause of death among Indigenous people aged 1 to 34 years). 
Across all disease groups, Indigenous males contributed an equal or greater share of the fatal 
burden than Indigenous females, with the exception of chronic musculoskeletal disorders 
and kidney and urinary diseases. Disparities between the sexes, when measured as a 
proportion of total years of life lost, were greatest for mental illnesses and behavioural 
disorders (65% male), injuries (70% male) and chronic musculoskeletal disorders (66% 
female). 
Two measures were used in this report to estimate the gap in fatal burden between 
Indigenous and non-Indigenous Australians: rate differences and rate ratios. Rate differences 
(primary gap measure) provide a measure of the absolute disparity or mortality gap between 
the two populations. Using rate differences, the total gap in fatal burden between Indigenous 
and non-Indigenous Australians in 2010 was 152 YLL per 1,000 population. The diseases that 
made the largest contribution to the gap in fatal burden were cardiovascular diseases 
(responsible for 27% of the gap), cancer and other neoplasms (15%), injuries (14%), and 
endocrine disorders (10%). Chronic diseases accounted for around 80% of the total gap in 
fatal burden between Indigenous and non-Indigenous persons aged 55 years and over in 
2010.  
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A useful secondary measure, the rate ratio, provides a measure of the relative disparity or 
gap in fatal burden between the Indigenous and non-Indigenous populations. After 
adjusting for differences in age structure, the rate of fatal burden of disease in 2010 in the 
Indigenous population was 2.6 times the rate in the non-Indigenous population. Endocrine 
disorders (which include diabetes), and kidney and urinary disease, had the highest 
Indigenous to non-Indigenous mortality rate ratios (7.9 and 6.6 respectively). While these 
rate ratios are much higher than for cardiovascular diseases, cancer and injuries, their 
contribution to the total mortality gap was lower (10% for endocrine disorders and 6% for 
kidney and urinary diseases). 
The diseases that will make the most difference to closing the gap in fatal burden between 
Indigenous and non-Indigenous Australians are cardiovascular diseases, cancers, injuries 
and endocrine disorders (which includes diabetes). Kidney and urinary diseases should also 
be considered as important due to their high relative disparity in fatal burden between the 
Indigenous and non-Indigenous populations. Continued effort in reducing Indigenous 
deaths from chronic diseases and injuries, through a combination of risk factor prevention, 
primary prevention and chronic disease management, is key to reducing Indigenous 
mortality in the future.  
The gap in the fatal burden between Indigenous and non-Indigenous Australians is seen 
across all disease groups, ages, both sexes, and the geographical classifications examined 
(state/territory and remoteness). Of the four states and territories for which Indigenous YLL 
estimates could be reliably calculated, Indigenous YLL rates were highest in the Northern 
Territory and Western Australia. In the Northern Territory and Western Australia, 
Indigenous Australians experienced fatal burden at more than 3 times the rate of non-
Indigenous Australians, and in Queensland and New South Wales, Indigenous Australians  
experienced fatal burden at 2.5 times the rate of non-Indigenous Australians. Across all four 
states and territories, cardiovascular diseases were the largest contributor to the gap in fatal 
burden between Indigenous and non-Indigenous Australians. Cancer ranked second in New 
South Wales, Queensland and the Northern Territory, while in Western Australia injuries 
were the second largest contributor to the gap. 
The rate of fatal burden of disease among Indigenous Australians was higher in Remote and 
Very remote areas compared to Major cities and regional areas. Disaggregating results by 
remoteness revealed differences in the diseases contributing the most to the fatal disease 
burden in the Aboriginal and Torres Strait Islander population. Kidney and urinary diseases 
ranked higher and contributed to a greater proportion of YLL in remote areas compared to 
non-remote areas. On the other hand, gastrointestinal diseases ranked higher and 
contributed to a greater proportion of YLL in non-remote areas.  
In this report, results are disaggregated by a measure of socioeconomic disadvantage as a 
way of showing disparities in Indigenous fatal burden across different social and economic 
groups and to highlight the importance of the social determinants of health. An Indigenous-
specific index of socioeconomic outcomes is used (Biddle 2013) which reflects the level of 
socioeconomic disadvantage experienced by Indigenous Australians living in each 
Indigenous Area in Australia. This showed a consistent gradient in YLL rates by 
socioeconomic quintile, with Indigenous persons living in the most socioeconomically 
disadvantaged areas experiencing the highest rate of YLL (261 per 1,000 population) and 
those in the least disadvantaged areas experiencing the lowest rate of YLL (91 per 1,000 
population). 
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Analyses presented in this report capture only the fatal burden of disease, and results will 
therefore overemphasise the relative importance of those conditions with a significant 
proportion of the fatal burden (for example, cancer) compared to largely non-fatal conditions 
(for example, mental disorders). Estimates produced in later stages of the ABDS (full report 
expected to be published in 2016) will combine the impact of premature death (YLL) with the 
illness or disability caused by a given disease or injury (YLD) into disability-adjusted life 
years (DALYs), and will also include the contribution of various risk factors to total burden 
of disease. This information will be critical to disease monitoring and health service 
planning, and could serve as the foundation for assessments of the economic impact of 
diseases and the cost-effectiveness of interventions targeting key risk factors for the 
Aboriginal and Torres Strait Islander population. 
Future work 
As discussed in Chapter 2, the ABS remoteness adjustment factors are only available for 
the two remoteness categories of Major cities/Inner regional combined, 
and Outer regional/Remote/Very remote combined. These combined remoteness categories 
are not considered the most useful to policymakers for examining mortality disparities by 
remoteness, given the wide variation between the five remoteness categories, and because 
the chosen groupings of remoteness (in particular, the combining of Outer 
regional with Remote and Very remote) masks any mortality disparities by remoteness—they 
do not follow the typical categories of non-remote and remote. Furthermore, Indigenous YLL 
estimates based on the ABS adjustment factors for these two grouped remoteness categories 
were very similar, which is somewhat counter-intuitive given the known higher rates of 
Indigenous mortality in remote areas—raising further questions about their usefulness.  
In early 2015, the ABS re-examined data collected as part of the 2011–12 Census Data 
Enhancement (CDE) Indigenous Mortality Study. The ABS confirmed that there are too few 
deaths in the Census to deaths linked dataset to calculate reliable adjustment factors for 
alternative grouped categories of remoteness, including Remote and Very Remote combined. 
The ABS undertook additional analyses to estimate Indigenous identification adjustment 
factors by the two grouped remoteness categories (Major cities/Inner regional combined, 
Outer regional/Remote/Very remote combined) for: 
• the four jurisdictions which are considered to have better quality Indigenous mortality 
data (New South Wales, Queensland, Western Australia and the Northern Territory); 
and  
• the other four jurisdictions which are considered to have poorer quality Indigenous 
mortality data primarily due to small population size (Victoria, South Australia, 
Tasmania and the Australian Capital Territory).  
These alternative adjustment factors were compared to the current ABS remoteness 
adjustment factors based on data from all states and territories. These analyses 
suggested that Indigenous identification in mortality data in New South Wales, Queensland, 
Western Australia and the Northern Territory combined is close to complete (99%) in Outer 
regional/Remote/Very remote areas compared to only 72% complete for the same regions in the 
remaining four jurisdictions combined. Furthermore, at 66%, Indigenous identification is 
estimated to be twice as high in mortality data for Major cities/Inner regional areas of the four 
jurisdictions combined with better quality mortality data, compared to just 33% for the other 
four jurisdictions combined (Victoria, South Australia, Tasmania and the ACT). Such low 
 Fatal burden of disease in Aboriginal and Torres Strait Islander people 2010 65 
levels of Indigenous identification (and therefore high adjustment factors) in the urban areas 
of Victoria, South Australia, Tasmania and the ACT combined leave some doubts about the 
reliability of YLL estimates derived from them. These alternative adjustment factors may be 
useful for more detailed future analyses and reporting of Indigenous mortality and fatal 
burden by remoteness. 
Consistent with previous burden of disease studies, the ABDS used the underlying cause of 
death (UCOD) to classify each death to a cause in the cause list. Use of the UCOD alone (that 
is, without associated causes) assigns the entire fatal burden to one cause, and thus cannot 
reflect more complex situations where more than one disease contributed to the death. For 
example, chronic kidney diseases and diabetes have causal pathways that are complex and 
interwoven with many other diseases, and are often listed as associated causes of death 
rather than as a UCOD. This may mean that the total fatal burden of these diseases cannot be 
fully ascertained from burden of disease estimates alone. Further development work may 
assess the use of associated causes of death to account for more complex situations. Another 
potential approach is to use ‘diseases-as-risks’ in the risk factor component of the analysis, an 
approach used in the most recent New Zealand burden of disease study (New Zealand 
Ministry of Health 2012). 
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Appendix A: Burden of disease studies 
Table A.1 provides a summary of global and Australian burden of disease studies 
undertaken. Some states and territories have also undertaken burden of disease studies 
based on the methods used in the 2003 Australian study, including the Northern Territory, 
South Australia, Victoria, Queensland and Western Australia.  
Table A.1: Summary of global burden of disease studies and Australian country studies 
Study Reference year Differences in methodologies Reference 
Global study: Harvard 
School of Public Health in 
collaboration with The 
World Bank and World 
Health Organization 
(WHO) 
1990 Life table represented highest observed life expectancies 
for females in mid-1990s. 
Discounting and age weighting. 
100+ diseases and injuries. 
Incident YLD. 
Murray & Lopez 
1996 
First Australian study: 
AIHW 
1996 3% discounting of YLL. 
No age weighting. 
175 causes. 
Incident YLD. 
AIHW: Mathers 
et al.1999 
Global study: World Bank  2000–2002 Discounting and age weighting.  
136 causes. 
Incident YLD. 
Lopez et al. 
2006 
Global study: WHO-
conducted global study 
2004 with 
projections to 2030 
Discounting and age weighting . 
136 causes.  
Incident YLD. 
WHO 2009 
Second Australian study: 
AIHW 
2003 3% discounting of YLL. 
No age weighting. 
186 diseases. 
Incident YLD. 
AIHW: Begg et 
al. 2007 
First Indigenous Australian 
study: University of 
Queensland 
2003 3% discounting of YLL. 
No age weighting. 
Adjustment for under-identification for deaths and 
population statistics. 
Incident YLD. 
Vos et al. 2007 
Global study: IHME  2010 New standard life table. 
No discounting or age weighting.  
241 diseases. 
Prevalent YLD. 
Major revision to disability weights. 
Change in definition of health to include health loss only. 
Uncertainty intervals calculated. 
Lancet 2012  
Global study: WHO 2011 No discounting or age weighting.  
Standard life table based on projections. 
163 diseases. 
Prevalent YLD. 
Some revisions to GBD 2010 disability weights. 
WHO 2014a 
Global Study: IHME 2013 Same methods as GBD 2010, with some minor revisions 
to disability weights. 
IHME 2014—not 
yet published 
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Appendix B: Data sources and standard 
life table 
Mortality data sources 
Mortality data come from the AIHW’s National Mortality Database. This is a historical 
register of all deaths in Australia since 1964. The database comprises information about the 
causes of death and other characteristics about the person, such as sex, age at death, 
Indigenous status and area of usual residence. The cause-of-death data are sourced from the 
Registrars of Births, Deaths and Marriages in each state and territory and the National 
Coronial Information System, and are coded to the ICD by the Australian Bureau of Statistics 
(ABS).  
Australian deaths data are collected through vital registrations. This is a system for collecting 
and maintaining records of life events (such as births, deaths and marriages) by a 
government authority. The AIHW website <http://www.aihw.gov.au/deaths/about-
deaths-data/> provides detailed information on the registration of deaths and the coding of 
causes of death in Australia (AIHW 2013). The completeness, accuracy and coding of these 
data are also described elsewhere (ABS 2014; AIHW 2013). The deaths data are collated into 
an administrative data set for statistical analysis. Given the high quality of these data, no 
adjustment needs to be made to account for completeness for national estimates. Some 
transformation of the data has been undertaken to reassign some deaths to fit the purposes 
of burden of disease analysis (see Appendix D Redistribution).  
Versions of the mortality dataset 
The analyses for this report include all deaths that occurred during 2009–2011 that were 
captured in the four cause of death unit record files (CODURFs) for 2009–2012 
(corresponding to deaths registered during 2009–2012). The version of these CODURFs is 
final for 2009 and 2010, revised for 2011 and preliminary for 2012. This methodology ensures 
that the latest and most accurate versions of the CODURFs are used for analysis. The process 
of revisions and the resulting versions of the CODURFs are described elsewhere (ABS 2014; 
AIHW 2013). Further revisions to the 2011 and 2012 CODURFs can result in changes to the 
estimates of causes of death, although these changes are expected to have only a small 
impact on estimates included in this report. 
Accounting for late registrations 
Using the CODURFs to 2012 for counting deaths that occurred in or before 2011 ensures that 
a sufficient number of late registrations are captured. On average, 95% of deaths are 
registered in the year in which they occur. Of the deaths that occurred in 2011, 5% were not 
registered until 2012 (ABS 2014). The inclusion of the 2012 CODURF enables these late 
registrations for 2011 to be used in calculating YLL estimates. A similar rationale applies to 
other years of data. This maximises inclusion of any very late registrations, such as those 
registered in Queensland in 2010, as described by ABS (2012).  
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Standard life table 
Life expectancy at birth and life tables 
Life expectancy measures how long, on average, a person is expected to live, based on 
current age- and sex-specific death rates in the population. It is a summary measure 
commonly used to describe the health of a population. It specifies the remaining life 
expectancy at each age, with life expectancy at birth being the most commonly used—the 
number of years of life that a person born today can expect to live. These estimates of life 
expectancy are derived from a life table, which summarises the pattern of mortality and 
survival in the population.  
As YLL is a ‘health gap’ measure, it requires definition of an aspirational life span to be able 
to quantify the gap between the current mortality and the counterfactual scenario where all 
mortality is averted until very old age. This is done using a standard life table—a key 
component of burden of disease studies. A standard life table corresponds to the aspirational 
or maximum life span for an individual in good health—it is not necessarily the actual life 
table of the population being studied. It is used to produce estimates of life expectancy at 
each age to indicate the number of years of life that are lost from dying at a specific age. For 
example, if the remaining life expectancy of a person aged 55 is 30 years (that is, at age 55 a 
person can expect to live to 85), a death at age 55 represents a loss of 30 YLL.  
Choice of standard life table 
The choice of standard life table will impact on burden of disease estimates. In general, a life 
table with longer life expectancy will result in greater YLL. 
A standard life table is used to enable comparisons between population groups and across 
time. The ABDS uses the standard life table used in GBD 2010 in the calculation of YLL. This 
life table represents a longer life span than the Australian life tables produced by the ABS, 
which are based on the mortality experience in the Australian population (see further 
information in the following section). The GBD standard life table is also used for Indigenous 
and sub-national estimates to maintain comparability with national estimates.  
Standard life tables used in global studies 
GBD standard life table 
The GBD 2010 standard life table was derived rigorously using mortality rates from multiple 
countries (Murray et al. 2012). It is based on the lowest observed age-specific death rates, 
capturing mortality patterns in all countries except those with very small populations, and 
covering all age ranges. The life expectancy estimates were assessed for predictive validity, 
including for countries with different levels of mortality. The result is a hypothetical life table 
giving estimates of life expectancy at birth to be 86.0 years for both males and females. Table 
B.1 shows an abridged version of the GBD 2010 standard life table. 
Some other features of this life table are that it: 
• is a standard; that is, it can be applied across multiple settings to enable comparisons 
between population groups and across time 
• is aspirational; that is, it reflects the lowest observed death rates to construct a measure of 
currently observed maximum life span 
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• applies to all population groups: that is, it assumes the same aspirational life expectancy 
for any population group. Importantly, it is the same for males and females, and thus 
assumes no male–female ‘biological’ differences in survival potential.  
The estimates of life expectancy in the GBD 2010 standard life table are, as expected, different 
from the estimates of life expectancy for the Australian population derived by the ABS. The 
latter are derived from actual mortality rates based on death registrations and the estimated 
resident population.  
Comparisons of the GBD 2010 standard life table values with life expectancies for the 
Australian population for the period 2008–2010 and for the Aboriginal and Torres Strait 
Islander population for the period 2010–2012, are shown for selected ages in Table B1. The 
life expectancies for Australian males and females at birth in 2008–2010 were 79.5 and 84.0 
years respectively, and 69.1 and 73.7 years for Indigenous males and females respectively 
(for 2010–12). These life expectancies are lower than the aspirational age of 86.0 years in the 
standard life table used for GBD 2010 estimates.  
Table B.1: Expected years of life remaining at selected ages using GBD standard and Australian life 
tables for 2008–2010 (Australia) and 2010–2012 (Indigenous) 
 Expected years of life remaining 
Age 
GBD 2010 
standard  Australia males  
Australia 
females   
Age and 
age 
(grouped) 
Indigenous 
males 
Indigenous 
females 
0 86.0  79.5 84.0  0 69.1 73.7 
1 85.2  78.9 83.3  1 68.7 73.2 
15 71.3  65.1 69.4  15–19 55.0 59.4 
25 61.4  55.4 59.6  25 45.7 49.8 
45 41.8  36.3 40.1  45–49 28.4 31.5 
65 23.3  18.9 21.8  65 13.9 15.8 
85 7.6  6.0 7.1  85 and over 4.2 4.4 
95 3.3  3.1 3.4  95 n.a. n.a. 
100 2.2  2.5 2.7  100 n.a. n.a. 
105 1.6  n.a. n.a.  105 n.a. n.a. 
n.a.  not available. 
Note: Australian life expectancy has been calculated using three years of data (2008–2010) for the total population, and 2010–2012 for the 
Indigenous population. 
Sources: Murray et al. 2012; ABS 2011; ABS 2013b. 
WHO standard life table 
The World Health Organization (2012) uses a different standard life table, with a higher 
aspirational life expectancy than the life table used for GBD2010 and Australian life tables 
(Table B.2). WHO argued that the GBD aspirational life expectancy was too low, as it is 
known that some level of preventable disease or injury still exists in populations; they also 
noted that the GBD aspirational life expectancy at birth has already been achieved in some 
populations (see WHO 2014b). Table B.2 compares Australian life expectancies for 2008–2010 
and Indigenous Australian life expectancies for 2010–2012 with those in the WHO standard 
life table for 2012.  
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Table B.2: Expected years of life remaining at selected ages using WHO 2012 standard and 
Australian life tables for 2008–2010 (Australia) and 2010–2012 (Indigenous) 
 Expected years of life remaining 
Age 
WHO 2012 
standard  Australia males  
Australia 
females   
Age, and 
age 
(grouped) 
Indigenous 
males 
Indigenous 
females 
0 91.9  79.5 84.0  0 69.1 73.7 
1 91.0  78.9 83.3  1 68.7 73.2 
15 77.0  65.1 69.4  15–19 55.0 59.4 
25 67.0  55.4 59.6  25 45.7 49.8 
45 47.0  36.3 40.1  45–49 28.4 31.5 
65 27.9  18.9 21.8  65 13.9 15.8 
85 10.7  6.0 7.1  85 and over 4.2 4.4 
95 5.1  3.1 3.4  95 n.a. n.a. 
100 2.8  2.5 2.7  100 n.a. n.a. 
105 1.0  n.a. n.a.  105 n.a. n.a. 
n.a. not available. 
Note: Australian life expectancy has been calculated using three years of data (2008–2010) for the total population, and 2010–2012 for the 
Indigenous population. 
Sources: WHO 2014a; ABS 2011; ABS 2013a. 
Impact of choice of standard life table  
As mentioned above, the standard life table from GBD 2010 has been adopted in the 
calculations of YLL for both Australian YLL estimates and Indigenous YLL estimates for the 
ABDS.  
The GBD 2010 standard life table has higher life expectancies than the life tables used in 
previous Australian and Indigenous burden of disease studies that were based on a standard 
life table that was internationally recognised and used in most other burden of disease 
studies at that time (the life expectancy at birth was 80.0 years for males and 82.5 years for 
females). As a result, estimates of YLL using the GBD 2010 standard life table will be greater 
than those produced for previous studies because the GBD life table estimates more years of 
life remaining at all ages to 85 years. The increase in life expectancy at birth to 86 years for 
both males and females in GBD 2010 also alters the YLL:YLD ratio by increasing the relative 
significance of fatal conditions. 
The GBD 2010 standard life table also has remarkably higher life expectancies than estimates 
based on recent Indigenous life tables (that is, 69.1 and 73.7 years at birth for Indigenous 
Australian males and females respectively in 2010–2012; ABS 2013b). Using the GBD 2010 
standard life table will emphasise deaths at younger ages and will result in substantially 
greater YLL, particularly for the Indigenous population, given that they tend to have more 
deaths at younger ages, and very small numbers of deaths at older ages. This may also 
impact on the gap in YLL between Indigenous and non-Indigenous Australians.  
The AIHW undertook sensitivity analyses to look at the impact of using different standard 
life tables on resulting Indigenous and non-Indigenous YLL, and the gap. The life tables 
examined included: the GBD 2010 standard life table, the life table used in the previous 
Australian and Indigenous BoD studies, the most recent ABS Indigenous and non-
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Indigenous life tables for 2010–2012, and the standard life table used in the WHO’s recent 
global burden of disease report (which has an even higher life expectancy than GBD 2010 
standard life table). This analysis supported the above discussions that life tables with longer 
life expectancies will lead to higher YLL. For example, using the WHO 2012 standard life 
table resulted in the highest number and rate of Indigenous YLL of all the life tables 
examined. Using the GBD 2010 life table results in a 12% higher number of Indigenous YLL 
than using the life table used in the 2003 Australian study, and a 23% higher number of 
Indigenous YLL than using the 2010–12 Indigenous life table (proportions calculated by 
dividing the difference in the number of Indigenous YLL calculated using the different life 
tables by the number of Indigenous YLL calculated using the GBD 2010 life table).  
In terms of the gap between Indigenous and non-Indigenous Australians, the WHO 2012 
standard life table, followed by the GBD 2010 standard life table, resulted in the largest  
age-standardised rate differences in YLL between the Indigenous and non-Indigenous 
populations; however, the rate ratio measure remained stable at between 2.1 and 2.2 
regardless of which life table was used (Table B3). Note that these estimates are based on 
unadjusted Indigenous deaths and therefore are not comparable to the YLL rates presented 
in the body of this report, which have been adjusted for Indigenous under-identification in 
mortality data. 
Table B.3: Age-standardised gap measures of YLL in 2006–2010 (unadjusted for Indigenous  
under-identification), based on different standard life tables 
Standard life table used  
Age-standardised rate of YLL (per 
1,000 population per year) 
   Indigenous Non-Indigenous   Rate difference Rate ratio 
GBD 2010 211.3 98.0 
 
113.2 2.2 
Aus BoD 2003  178.0 80.3 
 
97.6 2.2 
Non-Indigenous life table 2010–12 193.3 88.7 
 
104.5 2.2 
Indigenous life table 2010–12 156.5 72.8  83.8 2.2 
WHO 2012 250.0 120.0  130.0 2.1 
Source: AIHW analysis of AIHW National Mortality Database. 
In terms of policy and planning, the pattern and ranking of YLL across disease groups is 
more important than the absolute value of YLL. Sensitivity analyses undertaken by the 
AIHW using the same set of life tables as the above analyses showed that the ranking of 
disease groups did not change for the Indigenous or non-Indigenous populations depending 
on the life table used. Similarly, the ranking of diseases by their contribution to the gap (as 
measured by the rate difference) did not change. This suggests that the ranking of diseases is 
robust whichever standard life table is used. 
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Appendix C: Measures of socioeconomic 
disadvantage 
Census data have typically been used to create area-based measures of socioeconomic 
disadvantage in Australia. Area-based measures rely on the assumption that if an index is 
calculated at a low enough geographical level, the households within that area will be 
relatively homogenous. A particular limitation of all area-based measures is that they are 
prone to the ‘ecological fallacy’, that is, using aggregate data from a larger group of people to 
make inferences about a subpopulation of people within that group. This bias is of particular 
concern when measuring the socioeconomic characteristics of Indigenous Australians 
because in most geographical regions, measures of socioeconomic disadvantage are 
dominated by the non-Indigenous population due to its size relative to the Indigenous 
population (Biddle 2009). 
Socio-Economic Indexes for Areas (SEIFA)  
The Socio-Economic Indexes for Areas (SEIFA) are the most commonly used measures of 
socioeconomic advantage and disadvantage in Australia, and have been calculated by the 
ABS since 1991. However, as SEIFA scores for each geographical unit are calculated based on 
the socioeconomic characteristics of the entire population, they may not accurately reflect 
levels of socioeconomic disadvantage in the Indigenous population.  
Analysis conducted by Kennedy and Firman (2004) found that across Queensland, 
Indigenous residents consistently had lower SEIFA scores than the total population of the 
same geographical unit. They concluded that applying area-based measures calculated using 
total population data to a smaller sub-population, in particular the Indigenous population, 
could under-estimate the magnitude of disparity between the populations. Among the four 
SEIFA indexes, the Index of Relative Socio-economic Disadvantage (IRSD) summarises a 
range of information about the economic and social conditions of people and households 
within an area, based on 15 variables including information on language, education, 
employment, living conditions, family composition, and so on (see Table C.1).  
Table C.1: Variables used in constructing IRSD, 2011 
Variables based on Census data 
% of people who do not speak English well 
% of people aged 15 years and over who have no educational attainment 
% of employed people classified as low skill Community and Personal Service workers 
% of employed people classified as Machinery Operators and Drivers 
% of occupied private dwellings requiring one or more extra bedrooms 
% of people aged 15 years and over who are separated or divorced 
% of occupied private dwellings with no cars 
% of people under the age of 70 who have a long-term health condition or disability and need assistance with core activities 
% of one parent families with dependent offspring only 
% of occupied private dwellings paying rent less than $166 per week (excluding $0 per week) 
(continued) 
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Table C.1 (continued): Variables used in constructing IRSD, 2011 
Variables based on Census data 
% of people (in the labour force) who are unemployed 
% of people aged 15 years and over whose highest level of education is Year 11 or lower 
% of employed people classified as Labourers 
% of occupied private dwellings with no internet connection  
% of families with children under 15 years of age who live with jobless parents 
% of people with stated household equivalised income between $1 and $20,799 per year 
Source: ABS 2013a. 
The AIHW has conducted experimental work to look at the pattern of age-standardised YLL 
rates for both the Indigenous and non-Indigenous populations if SEIFA (IRSD quintiles) is 
used to classify their level of socioeconomic disadvantage. As shown in Figure C.1, while 
non-Indigenous YLL rates show a clear downward gradient with decreasing socioeconomic 
disadvantage, Indigenous YLL rates show a different pattern, with rates declining until the 
4th socioeconomic quintile, and then rising in the least disadvantaged quintile. This pattern 
is contrary to other available evidence on disparities by socioeconomic disadvantage in the 
Indigenous population (shown clearly when using an Indigenous–specific socioeconomic 
index). It is therefore likely that SEIFA, although it captures the socioeconomic characteristics 
of the general Australian population, is inappropriate for the Indigenous population.  
 
Note: ERP by Indigenous status and IRSD quintile are only available in Census years. As a result the rates are calculated using 2011 Indigenous 
and non-Indigenous ERP by IRSD quintile.  
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure C.1: Age-standardised YLL rates by Indigenous status and SEIFA (IRSD) quintile, 2010 
Indigenous Relative Socioeconomic Outcomes (IRSEO) Index 
As an alternative, this report uses the Indigenous Relative Socioeconomic Outcomes (IRSEO) 
index to analyse Indigenous fatal burden by socioeconomic disadvantage. This index was 
developed by Dr Nicholas Biddle of the Centre for Aboriginal Economic Policy Research 
(CAEPR). The index was constructed from 2011 Census data based on only the Indigenous 
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population in each Indigenous Area (Biddle 2013). Compared to SEIFA, the IRSEO index is 
based on a reduced list of nine variables taken from five domains: education, employment, 
occupation, income and housing (Table C.2).  
The index has been shown to be stable across the 2001, 2006 and 2011 censuses in terms of 
the socioeconomic disadvantage ranking of Indigenous areas over time.  
Table C.2: Variables used in constructing IRSEO, 2011 
Variables based on Census data 
% of population 15 years and over employed 
% of population 15 years and over employed as a manager or professional 
% of population 15 years and over employed full-time in the private sector 
% of population 15 years and over who have completed Year 12 
% of population 15 years and over who have completed a qualification 
% of population 15 to 24 years old attending an educational institution 
% of population 15 years and over with an individual income above half the Australian median 
% of population who live in a house that is owned or being purchased 
% of population who live in a house with at least one bedroom per usual resident 
Source: Biddle 2013. 
Pooled Index of Relative Socioeconomic Outcomes (PIRSEO) for 
Indigenous and non-Indigenous populations 
Due to the way it was constructed, the IRSEO index contains information on the relative 
socioeconomic position of Indigenous Australians in one area compared to another. 
However, it has no information on the difference between Indigenous and non-Indigenous 
outcomes in the area. However, a Pooled Index of Relative Socioeconomic Outcomes 
(PIRSEO) for the Indigenous and non-Indigenous populations has been designed to facilitate 
such comparisons. 
This index is based on the same nine variables as the IRSEO index. However, following the 
analysis presented for the 2006 Indigenous population in Biddle (2009), a separate index 
value is created for the Indigenous population in an area, as well as the non-Indigenous 
population. These are described below. 
• w_PIRSEO_Non_Indigenous—This is a ranking of the level of socioeconomic 
disadvantage of non-Indigenous Australians in the area. In essence, the Indigenous and 
non-Indigenous populations in the Indigenous Areas were treated as two separate 
observations. The two sets of areas were then pooled and ranked accordingly. They have 
been converted into SA2 data using the same population weighted concordances. 
• w_PIRSEO_Indigenous—This is the pooled ranking for the Indigenous population. This 
should only really be used when comparing with the non-Indigenous population. 
In essence, the two populations are treated as separate observations and pooled together into 
a single dataset. The index is constructed for 368 Indigenous Areas with a population count 
of at least 100 Indigenous and 100 non-Indigenous usual residents of age 15 years and over. 
It is created by pooling Indigenous and non-Indigenous area outcomes based on 736 
observations (one for Indigenous population and one for non-Indigenous population in each 
area). These are then ranked into percentiles with ‘1’ the most advantaged area, and ‘100’ the 
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most disadvantaged (Biddle 2013). All non-Indigenous observations fall into the percentiles 
of 1 to 60 (the three less disadvantaged quintiles) in this pooled dataset. This is because  
non-Indigenous Australians as a whole experience less socioeconomic disadvantage than 
non-Indigenous Australians. When their socioeconomic outcomes are measured by the same 
metrics as those of Indigenous Australians, the result show no areas where the non-
Indigenous population is in the bottom of the pooled distribution (percentiles 61–100). 
The AIHW has undertaken analyses to look at the pattern of crude YLL rates by 
socioeconomic disadvantage for the Indigenous and non-Indigenous populations when 
using the PIRSEO index values for the Indigenous and non-Indigenous populations. This 
shows a U-shaped pattern for the Indigenous population, with the highest YLL rates being in 
the most disadvantaged and least disadvantaged quintiles. For the non-Indigenous 
population, a downward slope in YLL rates by decreasing socioeconomic disadvantage was 
observed for the top three quintiles, with no YLL occurring in the bottom 2 quintiles (for 
reasons outlined above). 
Rescaled PIRSEO_non_Indigenous 
Due to the results described above using the PIRSEO index values not being particularly 
useful for examining disparities in fatal burden between the two population groups, and 
based on advice received from Dr Biddle, a rescaled set of index values for the non-
Indigenous population has been used in order to look at the distribution of YLL for the  
non-Indigenous population by socioeconomic disadvantage of the non-Indigenous 
population in the area. While not directly comparable to the Indigenous rates on the IRSEO 
index, this enables an examination of differences in the general pattern and variation by 
socioeconomic disadvantage in the fatal burden of disease for the two population groups. 
For the purposes of this report, we have named this rescaled set of index values, the rescaled 
Pooled Non-Indigenous Relative Socioeconomic Outcomes index (PNIRSEO). YLL rates by 
level of socioeconomic disadvantage for the non-Indigenous population use the PINIRSEO 
index applied to non-Indigenous deaths, using a ranking for the socioeconomic 
characteristics of non-Indigenous Australians in each Indigenous area, which is then 
converted to SA2 using population weighted concordances.  
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Appendix D: Cause list and redistribution   
Development of the cause list  
All deaths, regardless of their cause, are counted when estimating fatal burden. The cause list 
details the specific diseases and injuries for which estimates of the number of YLL, YLD and 
DALYs will be made. It is a classification which, in principle, is a set of mutually exclusive 
and collectively exhaustive categories of disease and injury. Accordingly, it covers all fatal 
and non-fatal health outcomes (for which health loss is measured).  
An Australian cause list was developed specifically for this study to fit with Australian and 
Indigenous Australian contexts; that is, the disease and cause groups are tailored to meet the 
needs of the Australian health-policy and health-monitoring environment. The cause list 
used in this study was developed with the following considerations: 
• coverage of Australian and Indigenous policy interests  
• inclusion of specific causes with a potentially large or rapidly increasing burden 
• feasibility of measuring mortality and prevalence for each cause. 
To help refine the categories, the cause list for this study was developed with reference to the 
cause lists used for GBD 2010 (Lozano et al. 2012), the recent New Zealand Burden of Disease 
study (MOH 2012) and the previous Australian study (Begg et al. 2007).  
Structure of the cause list  
The resulting cause list is hierarchical and has two levels. The highest level contains 
17 disease groups under which around 175 causes are classified. The disease groups and 
some examples of the types of causes in each disease group are shown in Table D.1.   
For estimating YLL, all categories in the cause list have been mapped to the International 
Statistical Classification of Diseases and Related Health Problems, Tenth Revision (2006 version) 
(ICD-10) (WHO 1992). Table D2 provides a list of ICD-10 codes for each disease group used 
for the 2010 fatal burden estimates in this report. 
The cause list plays a pivotal role in developing burden of disease estimates, and its structure 
and content may have an impact on some components such as data compilation, the 
application of some disability weights (in estimating YLD) and risk factor attribution. 
Importantly, when this report was prepared, the cause list was being further refined, with 
additional input from disease experts. Any future refinements to the cause list may result in 
changes to the number of deaths and to patterns of YLL by disease group and cause. 
Changes would be more noticeable at finer levels of disaggregation, such as the specific 
cause level, than at the disease group level. As a result, this report presents YLL estimates by 
disease group rather than by cause. The full report produced from the ABDS (scheduled for 
2016) will present estimates for fatal and non-fatal burden at the cause level.  
In this report, the disease group Injuries was constructed based on the external cause of the 
injury (for example, a fall or road traffic accident), and not the type of injury sustained (for 
example, a fractured femur or spinal cord injury). The final structure of the cause list for 
Injuries is still being determined, and may change for the full ABDS report. However, as the 
scope of injury deaths is not likely to differ, whether reporting by nature of injury or by 
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external cause, the disease group results are expected to be very similar regardless of the 
cause list structure.  
It is also important to note that the Australian cause list does not fully align with cause lists 
used in other studies. For example, the disease groups do not always include the same set of 
causes—in some circumstances, this can lead to different ICD-10 codes being used to count 
the same specific cause of death.  
Table D.1: Disease groups in the ABDS cause list with examples of causes in the disease group 
Disease group Short label Examples of causes 
Infections Infections HIV/AIDS, tuberculosis, gastrointestinal infections, pertussis 
Infant and congenital 
conditions 
Infant / congenital Pre-term birth complications, birth trauma and asphyxia, neural 
tube defects, congenital cardiovascular defects 
Cancer and other neoplasms Cancer Breast cancer, bowel cancer, lung cancer, prostate cancer  
Cardiovascular diseases Cardiovascular Coronary heart disease, stroke, rheumatic heart disease, 
peripheral vascular disease 
Respiratory diseases Respiratory Asthma, chronic obstructive pulmonary disease, interstitial 
pulmonary disease, pneumoconiosis 
Gastrointestinal diseases Gastrointestinal Upper gastrointestinal disorders, appendicitis, chronic liver 
disease, pancreatitis, non-infective inflammatory bowel disease 
Neurological conditions Neurological Dementia, Parkinson disease, motor neurone disease 
Mental illnesses and 
behavioural disorders 
Mental/behavioural Unipolar depressive disorders, schizophrenia, alcohol use 
disorders, drug use disorders, eating disorders 
Endocrine disorders Endocrine Type 1 and Type 2 diabetes mellitus 
Kidney and urinary diseases Kidney/urinary Chronic kidney disease, urinary incontinence 
Reproductive and maternal 
conditions 
Reproductive/maternal Maternal haemorrhage, obstructed labour, genital prolapse, 
infertility 
Chronic musculoskeletal 
disorders 
Musculoskeletal Osteoarthritis, gout, rheumatoid arthritis, chronic 
musculoskeletal pain syndromes 
Sense organ disorders Sense organs Cataract and other lens disorders, glaucoma, age-related 
macular degeneration, hearing loss 
Skin disorders Skin Psoriasis, acne, dermatitis and eczema, ulcers 
Oral disorders Oral Dental caries, periodontal disease 
Blood and metabolic disorders Blood/metabolic Haemophilia, iron deficiency anaemia, cystic fibrosis 
Injuries Injuries Road traffic accidents, suicide, drowning, falls 
Notes 
1. The causes shown here are examples; each disease group comprises a broader range of causes than is shown here. 
2. For the 2010 estimates, the disease group Injuries reflects deaths that had an external cause as the underlying cause (that is, deaths that 
implicitly involve injury). 
3. The short label for the disease group is used in some parts of this report for convenience. 
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Table D.2: Disease group and ICD-10 codes used for this report 
Disease group ICD-10 codes 
Infections A00–A39, A42–A46, A481, A482, A484, A488, A49–A99, B00–B17, B19–B92, B940, B941, B948, 
B949, B95–B97, B99, D849, G00–G07, G09, H65–H66, H70, J00–J22, J85, J86, N290, N330, 
N740, N741, N742, N743, N744, O98, P23, P350, P353, P370, P373, P374 
Infant and congenital 
conditions 
G80, P00–P22, P24–P29, P351, P352, P358, P359, P36, P371, P372, P375, P378, P379,  
P38–P96, Q00–Q07, Q20–Q28, Q35–Q37, Q380, Q382, Q383, Q384, Q385, Q386, Q387, Q388, 
Q39–Q60, Q62–Q64, Q75–Q81, Q85–Q87, Q890, Q891, Q892, Q893, Q894, Q897, Q898,  
Q90–Q98, Q990, Q991, Q992, Q998, R95 
Cancer and other 
neoplasms 
C00–C25, C30–C75, C77–C79, C81–C85, C88–C96, D00–D24, D26–D48 
Cardiovascular diseases G45, I00–I09, I11, I20–I45, I47–I48, I491–I499, I51–I52, I60–I69, I700–I702, I708, I71–I84, I86–I99 
Respiratory diseases D860, D862, D869, J30–J68, J70–J84, J90–J95, J98–J99 
Gastrointestinal 
diseases 
B18, I85, K20–K63, K67–K70, K710, K711, K713, K714, K715, K716, K717, K718, K719, K72–K91, 
K928, K93 
Neurological conditions F00–F03, G08, G10–G13, G20–G44, G46–G73, G90–G99 
Mental illnesses and 
behavioural disorders 
F04–F33, F340, F341, F40–F98, X41–X42, X45 
Endocrine disorders E03–E07, E100, E101, E103–E109, E110–E111, E113–E119, E120–E121, E123–E129,  
E130–E131, E133–E139, E140–E141, E143–E149, E15–E27, E280, E281, E283, E288, E289, 
E29–E35, E89, O240, O241, O242, O243 
Kidney and urinary 
diseases 
E102, E112, E122, E132, E142, I12, N00–N16, N18, N20–N28, N291, N298, N30–N32, N338, 
N34–N42, Q61 
Reproductive and 
maternal conditions 
D25, E282, N43–N50, N62–N64, N75–N83, N91–N99, O00–O23, O244, O249, O25–O92,  
O95–O97, O99 
Chronic musculoskeletal 
disorders 
M00–M99 
Sense organ disorders H25–H27, H30–H35, H40, H43–H47, H48–H54, H60–H61, H68–H69, H71–H74, H80–H83, H90, 
H91, H92–H93  
Skin disorders L00–L05, L08, L10–L14, L20–L30, L40, L41–L45, L50–L60, L62–L68, L70–L75, L80–L95, L97–L99 
Oral disorders K00–K14 
Blood and metabolic 
disorders 
D50–D64, D66–D83, D840, D841, D848, D861, D863, D868, D89, E00–E02, E40–E67, E70–E84, 
E850–E852, E88, E90 
Injuries V01–V99, W00–W99, X00–X40, X43, X44, X46–X58, X60–X99, Y00–Y09, Y35–Y86, Y870, Y871, 
Y88, Y890, Y891 
Notes 
1. The ICD-10 codes used for allocating deaths to a disease group are presented here in ranges of ICD-10 codes. These code ranges may 
include a ICD-10 code that is not used for coding the UCOD (that is, an asterisk code). All analyses in this report are based on the UCOD 
only and therefore there will be no YLL reflecting causes with an asterisk code. 
2. The disease group Cancer and other neoplasms includes some malignant, in situ and benign neoplasms. For some cancers, such as breast 
and bowel cancer, this group covers malignant neoplasms only. 
3. The disease group Reproductive and maternal conditions includes causes of ill health that affect males and females. Consequently, some 
burden for this disease group will be apparent for males. However, due to the nature of maternal conditions, burden will be noticeably larger 
for females than for males. 
4. The disease group Injuries uses the external cause of death to identify deaths that implicitly involve injury. 
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How are deaths redistributed in the ABDS? 
The AIHW undertook a series of analyses investigating four methods for redistribution: 
• Direct evidence—this approach uses direct evidence about the particular deaths 
identified for redistribution (that is, those with a particular UCOD) from data linkage 
studies or sources other than the National Mortality Database. 
• Direct MCOD method—this method uses the tabulation of associated causes of death for 
death records where the redistribution code is the underlying cause. As the associated 
causes of death for redistribution causes are often also redistribution codes, this is likely 
to limit the usefulness of this method. 
• Indirect MCOD method—this method uses the tabulation of the UCOD where the 
redistribution code is reported as an associated cause of death. The corresponding 
UCODs and their proportional distribution provide the redistribution algorithm.  
• Proportional redistribution—this method reassigns deaths across a specified range of 
target causes according to the existing distribution of causes in the selected disease 
groups. This has the advantage of being a conceptually simple approach; however, it is a 
relatively blunt method as the distribution of existing causes may not necessarily reflect 
more probable underlying causes of death for the particular situation. Because of this, it 
was considered to be appropriate only for selected cases, such as low-volume 
redistribution causes.  
As a general guide, where direct evidence was available and expert advice had been sought, 
the algorithm from the direct evidence was applied. Failing this, where the redistribution 
cause was a frequently occurring cause of death, the indirect MCOD method was applied. 
Where the indirect MCOD did not suit the redistribution purposes, or where the 
redistribution cause was infrequent, a proportionate allocation was carried out using the 
GBD algorithms to guide the target cause categories. The direct MCOD method was not used 
for any redistribution in this report. 
Identifying potential direct evidence for redistribution causes is being assisted by the expert 
panels for the disease groups. Similarly, further application of the indirect MCOD and other 
redistribution approaches will be reviewed by disease experts before the full reports from 
this study are published. 
As described in Chapter 2, refining the cause list may change the number of deaths and 
patterns of YLL by disease group and cause. A similar effect can arise from changing the set 
of causes of death marked for redistribution and the range of causes selected as target causes. 
Changes would be more noticeable at finer levels of disaggregation, such as at the specific 
cause level rather than at the disease group level. 
The redistribution causes and the methods applied for this report are described in Table D.3, 
and the ICD-10 codes used to identify deaths for redistribution are in Table D.4.  
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Table D.3: Summary of redistribution methods by cause  
Redistribution methods and cause groups Target disease groups and causes 
Proportional allocation  
All cardiac conduction disorders, disorders of electrolyte and fluid 
imbalance, all encephalopathy and cerebral oedema, all hydrocephalus, 
cardiogenic shock and other shock, cardiac arrest, respiratory failure, 
different paralytic and palsy syndromes, fever, malaise, febrile convulsion, 
unknown origin, gastrointestinal signs and symptoms, other ill-defined 
causes, peritonitis, senility, sequelae of different diseases and injury, 
unspecified liver disease 
All  
Events of undetermined intent, exposure to unspecified factor Injuries 
Amyloidosis, cachexia, respiratory signs and symptoms Non-communicable and communicable 
disease groups 
Atherosclerosis, cardiac signs and symptoms, unspecified congenital 
malformations, unspecified chromosomal abnormality  
Non-communicable disease groups 
excluding Cancer 
Ill-defined cancers Cancer 
Direct evidence  
Disease of digestive system unspecified 
Ill-defined digestive cancers  
Unspecified site cancer 
Digestive diseases—selected causes only 
Cancer—selected digestive cancers 
Cancer 
Indirect MCOD methods  
Septicaemia, pneumonitis All 
 
Hypertension, heart failure All excluding Injuries 
Renal failure 
 
2-step method: Unspecified renal failure to 
acute and chronic renal failure and then 
acute renal failure over all disease groups 
excluding Injuries 
Table D.4: ICD-10 codes used to identify deaths for redistribution 
 ICD-10 codes 
Redistribution A40, A41, A480, A483, B942, C26, C76, C80, C97, D65, E68, E853–E859, E86–E87, F348, F349, 
F38–F39, F99, G81–G83, H00–H05, H06–H22, H28, H36, H42, H55–H59, H62, H67, H75,  
H94–H95, I10, I13–I15, I46, I490, I50, I709, J30, J69, J96, K65–K66, K712, K920, K921, K922, 
K929, N17, N19, N51, N60–N61, N70–N73, N748, N84–N90, O94, Q10–Q18, Q30–Q34, Q381, 
Q65–Q74, Q82–Q84, Q899, Q999, R00–R94, R96–R99, X59, Y10–Y34, Y872, Y899, Y90–Y98 
Note: Injury-related redistribution causes are identified on the basis of the external cause of injury. 
Testing of redistribution methods for Indigenous deaths  
The AIHW undertook analyses to ascertain whether the same redistribution algorithms 
derived for the total Australian population would be suitable to apply to Indigenous deaths, 
and to assess the stability in algorithms derived based on Indigenous deaths at the age group 
and sex levels.  
Results from these analyses showed that the total-population algorithms developed remain 
stable across time, both in terms of the types of underlying conditions reported and their 
respective proportions. For Indigenous deaths, however, results showed much more 
variability in the types of underlying causes reported and their respective proportions, 
depending on the years examined. This is due to the much smaller numbers of Indigenous 
deaths reported for each of the redistribution codes.  
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As a result, the same redistribution methods and algorithms have been used to redistribute 
total Australian deaths and Indigenous deaths. Using the same algorithms for Indigenous 
and non-Indigenous deaths provides comparability in the YLL estimates produced.  
Redistribution results 
In this report, the 2009–2011 deaths data were combined to produce deaths and YLL 
estimates. Results for 2010 are reported as annual average number of deaths, or YLL for 
2009–2011. This can reduce year-to-year fluctuations and provide greater stability for YLL 
estimates. Redistribution was undertaken for deaths that occurred in 2009–2011, and the 
results shown here reflect the annual average, referred to as the 2010 reference period. 
Deaths identified for redistribution were classified to one of the redistribution cause groups 
shown in Table D1. The classification of causes to these groups followed as closely as 
possible the GBD 2010 classification of redistribution codes.  
In 2010, a total of 208 Indigenous deaths were identified for redistribution (Table D.5). That 
is, they were coded with a cause that could not be ascribed to a burden of disease cause for 
one of the reasons outlined in Chapter 2. These deaths represented 8% of all Indigenous 
deaths used in the mortality analysis, which was slightly lower than the proportion of deaths 
identified for redistribution for the total Australian population (10%). 
Indigenous deaths identified for redistribution equated to 6,824 YLL in 2010, or 8% of total 
YLL.  
Table D.5: Number of Indigenous deaths and YLL from deaths identified for redistribution,  
2009–2011 (and average annual for 2010) 
 
Deaths  YLL 
Age group Males Females Persons  Males Females Persons 
2009–2011        
0–14 34 19 53  2,904 1,622 4,526 
15–24 15 4 19  1,002 269 1,272 
25–44 56 40 96  2,755 2,009 4,764 
45–64 102 84 186  3,370 2,800 6,170 
65–84 105 115 220  1,722 1,767 3,488 
85–94 n.p. n.p. 39  78 147 225 
95+ n.p. n.p. 10  5 23 28 
All ages 327 296 623  11,836 8,637 20,473 
2010 (average 
annual), all ages  109 99 208 
 
3,945 2,879 6,824 
Note: Some cells in this table are not published due to small numbers. Totals may not add due to rounding. 
Source: AIHW analysis of the AIHW National Mortality Database. 
Impact of redistribution  
This section describes the changes in the number of Indigenous deaths and YLL at the 
disease group level pre- and post-redistribution (Table D.6, Figure D.1). The biggest absolute 
change in the number of Indigenous deaths from redistribution was for Cancer and other 
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neoplasms (79 deaths), followed by Cardiovascular diseases (36 deaths) and Injuries (31 deaths). 
The biggest proportional change in the number of deaths from redistribution was for Skin 
disorders (although this was an increase of only 1 death), as well as for Cancer and other 
neoplasms, which both increased by around 18%. This was followed by Infant and congenital 
conditions, for which deaths rose by 12%. These increases in the number of deaths were 
similarly reflected in the change in the number of YLL pre- and post-redistribution. 
Figure D.1 provides a visual representation of these differences (for number of deaths and 
YLL) for each disease group pre- and post-redistribution. 
It is interesting to note that patterns of deaths pre- and post- redistribution were different for 
the total Australian population. The largest absolute change in the number of deaths and 
YLL pre- and post-redistribution was for Kidney and urinary diseases, which increased by 23% 
for males and 28% for females (AIHW 2015).  
Table D.6: Number of deaths and YLL for Indigenous Australians, pre- and post-redistribution, by 
disease group, 2010 
 Pre  Post  Absolute 
change 
(number) 
% 
change Disease group Number %  Number %  
  Deaths 
Infections 69 2.8  73 3.0  4 6.2 
Infant and congenital 90 3.7  101 4.1  11 12.2 
Cancer and other neoplasms 451 18.4  530 21.6  79 17.5 
Cardiovascular diseases 582 23.7  618 25.2  36 6.2 
Respiratory diseases 146 5.9  153 6.2  7 4.7 
Gastrointestinal diseases 140 5.7  152 6.2  12 8.6 
Neurological conditions 91 3.7  98 4.0  7 7.7 
Mental illnesses and behavioural disorders 46 1.9  48 2.0  2 4.2 
Endocrine disorders 166 6.8  171 7.0  5 3.0 
Kidney and urinary diseases 90 3.7  98 4.0  9 9.8 
Chronic musculoskeletal disorders 15 0.6  17 0.7  2 11.2 
Skin disorders 5 0.2  6 0.2  1 18.2 
Blood and metabolic disorders 32 1.3  35 1.4  3 8.3 
Injuries 324 13.2  355 14.4  31 9.4 
All other disease groups <3 n.p.  <3 n.p.  0 0.0 
Redistribution 208 8.5  0 0.0  –208 –100.0 
All diseases 2,457 100.0  2,457 100.0  0 0.0 
(continued) 
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Table D.6 (continued): Number of deaths and YLL for Indigenous Australians, pre- and post-
redistribution, by disease group, 2010 
 Pre  Post  Absolute 
change 
(number) 
% 
change Disease group Number %  Number %  
  YLL 
Infections 2,598 3.1  2,763 3.3  166 6.4 
Infant and congenital 7,497 8.9  8,392 10.0  895 11.9 
Cancer and other neoplasms 12,103 14.4  14,278 17.0  2,175 18 
Cardiovascular diseases 16,797 20.0  17,593 20.9  795 4.7 
Respiratory diseases 3,519 4.2  3,684 4.4  165 4.7 
Gastrointestinal diseases 4,947 5.9  5,264 6.3  317 6.4 
Neurological conditions 2,065 2.5  2,254 2.7  189 9.1 
Mental illnesses and behavioural disorders 1,768 2.1  1,844 2.2  76 4.3 
Endocrine disorders 4,336 5.2  4,455 5.3  119 2.7 
Kidney and urinary diseases 2,335 2.8  2,552 3.0  217 9.3 
Chronic musculoskeletal disorders 443 0.5  490 0.6  47 10.6 
Skin disorders 49 0.1  173 0.2  24 15.8 
Blood and metabolic disorders 943 1.1  1,050 1.3  107 11.4 
Injuries 17,568 20.9  19,100 22.7  1,532 8.7 
All other disease groups 89 0.1  89 0.1  0 0.0 
Redistribution 6,824 8.1  0 0.0  –6,824 –100.0 
All diseases 83,980 100.0  83,980 100.0  0 0.0 
Note: At the time of writing this report AIHW guidelines, to ensure confidentiality, required the suppression of cells based on less than three 
deaths. In this table these cells are represented by <3. 
Source: AIHW analysis of the AIHW National Mortality Database. 
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Source: AIHW analysis of the AIHW National Mortality Database. 
Figure D.1: Percentage of deaths and YLL for Indigenous Australians, pre- and post-redistribution, 
by disease group, 2010 
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Appendix E: Methods for adjusting 
Indigenous mortality data  
What is Indigenous under-identification? 
Despite improvements in recent years, there are continuing problems with the under-
identification of Aboriginal and Torres Strait Islander people in many health-related data 
collections. Under-identification occurs when Indigenous status is not correctly collected or 
accurately recorded for all persons. Incorrect or inconsistent data collection can lead to the 
Indigenous status of Aboriginal and Torres Strait Islander clients being incorrectly reported 
as non-Indigenous, or as ‘not stated’.  
The degree of under-identification in data sets can vary across different jurisdictions, sectors 
and service providers, due to varying standards of data collection practices and systems. 
However, it is important to note that Indigenous people (or their families) may choose to 
identify themselves as such in one situation and not in another, and thus identification can 
be thought of as a social construct underpinned by self-identification. 
Overall under-identification, and variations in the degree of under-identification across 
collections, can create difficulties for measuring the gap in health outcomes between 
Indigenous and non-Indigenous Australians, and for monitoring progress in closing the gap. 
Indigenous identification in mortality data 
It is likely that most deaths of Aboriginal and Torres Strait Islander people are registered in 
Australia’s vital registration system. However, a proportion of deceased persons are not 
identified as Aboriginal or Torres Strait Islander people by the family, health worker or 
funeral director during the death registration process. The incompleteness of Indigenous 
identification means the number of deaths recorded as Indigenous result in underestimates 
of the true levels of mortality in this population, and consequently an underestimate of the 
mortality gap between Indigenous and non-Indigenous Australians. The under-identification 
of Indigenous status at death has been shown to vary by age, state/territory, remoteness and 
over time.  
Indigenous mortality data can be adjusted to take account of under-identification in order to 
provide more reliable estimates of the fatal burden experienced by Aboriginal and Torres 
Strait Islander people.  
The 2003 Indigenous burden of disease study adjusted Indigenous mortality data using the 
general growth balance (GGB) method. This is an indirect mortality estimation method that 
compares population counts from two successive censuses with the deaths recorded in the 
period between censuses, while taking into consideration the change in Census coverage. 
Indirect methods are no longer considered a suitable method for Indigenous mortality 
estimation as they rely on high quality data of population census counts, and require a 
number of assumptions to be made about the characteristics of the Indigenous population to 
measure the under-reporting of Indigenous deaths (AIHW 2011). Instead, direct methods 
which use data linkage to derive Indigenous deaths have been found to be superior (Barnes 
et al. 2008) and are now recommended by the ABS (2009). 
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The ABDS uses direct methods based on data linkage studies to adjust for under-
identification in Indigenous deaths for YLL calculations. These studies and methods are 
described below.  
Indigenous mortality identification studies  
There have been a number of national and state/territory data linkage studies recently 
undertaken to ascertain levels of under-identification of Aboriginal and Torres Strait Islander 
deaths in death registration records. These have each produced adjustment factors which can 
be applied to Indigenous mortality data.  
The ABDS has drawn on two national studies undertaken by the ABS and AIHW to adjust 
Indigenous deaths for under-identification, which are described below. 
ABS Census Data Enhancement (CDE) Indigenous Mortality Study  
The ABS CDE Indigenous Mortality Study (referred to as the CDE Study hereafter) involved 
probabilistically linking Census records with death registration records to examine 
differences in the reporting of Indigenous status across the two datasets in order to estimate 
the ‘true’ number of Indigenous deaths. The expected number of Indigenous deaths in the 
year following the Census was estimated by adjusting linked Indigenous deaths according to 
propensities of being Indigenous in the Post Enumeration Survey (PES), given Indigenous 
status in the Census. This adjustment was made to ensure that the classification of records as 
Aboriginal and Torres Strait Islander occurs in a consistent manner in both the population 
data and the deaths data. 
The first ABS CDE Study was completed in 2008 using data from the 2006 Census. The  
2011–12 CDE Study linked 2011 Census records with all registered deaths that occurred from 
10 August 2011 to 27 September 2012 and produced a linked dataset consisting of 142,697 
deaths.  
Indigenous identification rates were computed by dividing the number of registered deaths 
reported as Indigenous by the expected number of Indigenous deaths in the Census. The 
resulting identification rates were used to derive factors for adjusting Indigenous deaths. 
The 2011–12 CDE Study produced three sets of adjustment factors (see Table E.1 below): 
1. Headline estimates, which include a national estimate and estimates for three broad age 
groups. 
2. Selected state and territory-specific estimates (individual estimates for New South Wales, 
Queensland, Western Australia and the Northern Territory, and a combined estimate for 
Victoria/South Australia/Tasmania/Australian Capital Territory). 
3. Remoteness area estimates (two broad categories at the national level).  
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Table E.1: Indigenous adjustment factors based on the ABS’s CDE Study 2011–12 
 Disaggregation Adjustment factor 
Headline estimates 0–14 years 1.21  
15–59 years 1.12  
60 years + 1.29  
Total 1.21  
State/territory estimates NSW 1.42  
 Qld 1.24  
 WA 1.14  
 NT 0.96  
 Vic/SA/Tas/ACT/Other Territories combined 2.49  
 Total(a) 1.39  
Remoteness area 
estimates Major cities and Inner regional 1.77  
 Outer regional, Remote and Very remote 1.04  
 Total(a) 1.39  
(a) These estimates are not the headline estimates for Australia, because they are calculated without an age-adjustment, but are provided to 
enable effective comparison with state and territory estimates and remoteness area estimates. 
Source: ABS 2009; ABS 2013b.  
The headline adjustment factors from the 2011–12 CDE Study were calculated using an 
improved methodology from the previous Study undertaken in 2006 which takes into 
account age-specific identification rates. The adjustment factors by state/territory and by 
remoteness area were estimated using a similar method, but without the age-specific 
adjustment. Due to small numbers of Indigenous people in Victoria, South Australia, 
Tasmania and the Australian Capital Territory, the ABS derived a combined adjustment 
factor for those four jurisdictions. Similarly, due to the small number of Indigenous deaths 
recorded for some remoteness categories, the ABS derived 2 combined adjustment factors for 
remoteness (Major cities/Inner regional combined, and Outer regional/Remote/Very remote 
combined). 
An adjustment factor below 1.0 indicates that a higher number of people identified as 
Indigenous at death registration compared with the number identified as Indigenous 
through linkage to the Census (with PES adjustment). 
The headline estimates show an Indigenous identification rate of 82% in the death 
registration data, and a corresponding adjustment factor of 1.21 for total deaths. Therefore, 
multiplying the registered number of Indigenous deaths by 1.21 will result in a 21% increase 
in the number of Indigenous deaths.  
AIHW Enhanced Mortality database project 
The AIHW Enhanced Mortality Database (EMD) project (referred to as EMD Study hereafter) 
links registered deaths in the AIHW National Mortality Database with Indigenous death 
records from alternative data sources, including a residential aged care data set, hospitals 
data, and neonatal deaths from the National Perinatal Data Collection. This study includes 
deaths registered during the period 2001–2010. 
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An ‘ever-Indigenous’ approach is used in determining Indigenous status from the various 
data sets, included in the linkage. This approach accepts that the deceased was Indigenous if 
indicated by any of the data sets included in the linkage. Adjustment factors produced from 
the AIHW’s EMD study take into account under-identification in mortality data only. They 
do not take into account under-identification in Indigenous population estimates as the 
ABS’s CDE Indigenous Mortality Study does.  
The first phase of the project was completed in 2010 which linked deaths for the period  
2001–2006 (AIHW 2012b). The linkage of the additional data sets to the death registration 
data set identified 10% more deaths than the 10,547 originally recorded on the death 
registration data set as ‘Indigenous’. 
The second phase of the project has involved linking deaths for the period 2001 to 2010, for 
which results are currently being reviewed. To closely approximate the years of mortality 
data used for reporting YLL estimates for the ABDS, adjustment factors have been calculated 
for the three-year period 2008–2010 for which there were 8,426 Indigenous deaths identified 
based on the ‘ever-Indigenous’ approach. In terms of sample size, this is larger than the 2,156 
Indigenous deaths identified in the Census data and included in the ABS’s 2011–12 CDE 
Study.  
Preliminary adjustment factors have been estimated for two sets of age groups by sex (the 
three broad age groups used in the 2011–12 CDE Study and 5 narrower age groups), as well 
as for all states and territories and all five remoteness categories (see Table E.2).  
Results from the EMD project for the period 2008–2010 identified 13% more Indigenous 
deaths than the number recorded in death registrations data, corresponding with an overall 
adjustment factor of 1.13. This is slightly higher than the 10% additional deaths identified 
from the AIHW EMD study for the period 2001–2006, and lower than the 21% additional 
deaths identified from the ABS 2011–12 CDE Study. 
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Table E.2: Indigenous mortality adjustment factors based on the AIHW EMD (2008–2010)  
  Age group Males Females Persons 
Three age groups 
0–14 1.16 1.10 1.13 
15–59 1.06 1.08 1.07 
60+ 1.20 1.18 1.19 
Total 1.12 1.14 1.13 
Five age groups 
0–14 1.16 1.10 1.13 
15–34 1.02 1.05 1.03 
35–54 1.07 1.09 1.08 
55–69 1.14 1.11 1.13 
70+ 1.24 1.22 1.23 
Total 1.12 1.14 1.13 
State/territory 
NSW   1.21 
Qld   1.12 
WA   1.06 
NT   1.01 
Vic   1.34 
SA   1.13 
Tas   1.57 
ACT   1.34 
Remoteness(a) 
Major cities   1.25 
Inner regional    1.22 
Outer regional   1.12 
Remote   1.04 
Very remote   1.02 
(a) Concordance was done to derive remoteness categories based on SLA information in the AIHW EMD data. Since 
some SLA information in the dataset cannot be mapped to remote categories, there are 5% of Indigenous mortality 
records (based on the ‘ever-Indigenous’ approach) with a missing or unassigned remoteness category. These records 
have been excluded from the calculation.  
Source: AIHW Enhanced Mortality Data study (forthcoming). 
Sensitivity analyses—impacts of using AIHW and ABS adjustment 
factors on YLL estimates 
The AIHW undertook a series of sensitivity analyses using 2008–2010 mortality data to 
examine the impact of different adjustment factors on resulting Indigenous YLL and gap 
measures. In particular we wanted to see whether the same general patterns held regardless 
of which adjustment factors were used. Estimates based on the ABS adjustment factors from 
the 2011–12 CDE Study were compared to estimates based on the AIHW adjustment factors 
from the EMD study.  
These analyses suggested that the absolute magnitude of the number and rate of Indigenous 
YLL was greater when using the ABS adjustment factors compared to the AIHW adjustment 
factors. For example the total average annual Indigenous YLL for 2008–2010 was 95,732 (17% 
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increase from unadjusted YLL) when using the ABS adjustment factors compared to 90,184 
(10% increase from unadjusted YLL) when using the AIHW adjustment factors.  
However, the general pattern for YLL rates by age group and the ranking of disease groups 
remained the same when using both sets of adjustment factors. Similarly, the percentage 
contribution to total fatal burden in the Indigenous population was almost identical when 
using AIHW and ABS adjusted estimates. For example, injuries and cardiovascular diseases 
were the leading contributors to fatal burden in the Indigenous population (both 21% based 
on AIHW adjustment factors and 21–22% based ABS adjustment factors), followed by cancer 
(17% for both sets of estimates). 
In regards to estimates of the gap between Indigenous and non-Indigenous fatal burden, the 
ABS adjusted estimates produced slightly higher rate ratios than the AIHW adjusted 
estimates (2.6 compared to 2.4); however both sets of estimates show the same general 
ranking and pattern in terms of the leading causes of the gap (based on rate differences as 
the gap measure) at the national level (see Figure E.1 below). 
Note that because these sensitivity analyses were undertaken using deaths for the three-year 
period 2008–2010, the number and rates of YLL will differ slightly to the results presented in 
Chapter 3 of this report which use deaths for 2009–2011. 
 
Source: AIHW analysis of the AIHW National Mortality Database. 
Figure E.1: Age-standardised YLL rate differences between Indigenous and non-Indigenous 
Australians, by disease group and adjustment factor, 2008–2010 (average annual figures) 
Differences between the estimates produced based on ABS adjustment factors compared to 
AIHW adjustment factors are likely to be due to key differences between the ABS and AIHW 
data linkage studies from which the adjustment factors were derived. For example, the ABS 
CDE study probabilistically linked Census records with death registration records, and the 
adjustment factors were developed based on the ‘gold standard’ of people’s Indigenous 
status in the ABS’s Post-Enumeration Survey. Using these factors to adjust Indigenous 
deaths, in theory, ensures consistency between numerator (death numbers or YLL) and 
denominator (Indigenous Estimate Resident Population). The AIHW’s EMD Study was 
based on an ‘ever Indigenous’ approach, which itself is based on four administrative data 
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sets and does not take into account under-identification in ERP calculations. Another 
difference is that the two studies use slightly different time frames for examining Indigenous 
deaths—the ABS study relates to the period 2011–12, while the AIHW study relates to the 
period 2008–2010. As Indigenous identification can legitimately change over a short period, 
this may also partly contribute to the differences observed between the adjusted estimates 
derived using the ABS and AIHW linkage studies. 
Strengths and limitations of the ABS and AIHW adjustment factors 
The key strengths of the ABS CDE Study and adjustment factors are: consistency in 
adjustments for under-identification in both the numerator and denominator used in 
Indigenous YLL calculations; and authority—the ABS adjustment factors are the official 
estimates of Indigenous mortality coverage in Australia (used to produce the ABS’s 
Indigenous life expectancy estimates).  
A key strength of the AIHW EMD Study is that it was able to produce Indigenous mortality 
adjustment factors for all eight states and territories and five remoteness categories, due to 
the larger sample size included in the study. 
Common limitations of both the ABS and AIHW data linkage studies include: 
• While age-specific adjustment factors were calculated at the national level, adjustment 
factors produced by state/territory and remoteness do not include an age-specific 
adjustment for under-identification (as the sample sizes of the studies were insufficient 
to accurately calculate age-specific identification rates at these levels of disaggregation). 
• Cause-of-death information was not included in the data linkage, and thus any 
differences in identification by cause of death are not taken into account in adjustment 
factors produced (other than those that are due to differences in the age-profile of the 
disease, which are captured in national adjustment factors only).  
• No adjustment factors are available by any measure of socioeconomic disadvantage. 
The ABS CDE Study and available adjustment factors have a number of additional 
limitations, including: 
• State/territory adjustment factors are only available for New South Wales, Queensland, 
Western Australia and the Northern Territory individually. A combined adjustment 
factor was calculated for the other four jurisdictions (Victoria, South Australia, Tasmania 
and the Australian Capital Territory). However, application of this combined adjustment 
factor results in an implausibly high Indigenous YLL estimate for the four combined 
jurisdictions, and disaggregation of the combined factor to produce individual 
jurisdictional estimates also produces somewhat implausible YLL results.  
• Adjustment factors for remoteness are currently only available for 2 combined 
remoteness categories (Major cities/Inner regional combined and Outer 
regional/Remote/Very remote combined). Reporting YLL estimates for these combined 
remoteness categories is not considered useful to policymakers for examining mortality 
disparities by remoteness, given the wide variation between the five remoteness 
categories, and because the chosen groupings of remoteness (in particular, the 
combining of Outer regional with Remote and Very remote) mask any mortality disparities 
by remoteness—they do not follow the typical categories of non-remote and remote. 
It is important to note that despite the attempt to remove bias in the results through 
adjustments made to Indigenous deaths for calculating YLL estimates presented in this 
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report, there is still a degree of uncertainty around the true level of mortality among 
Indigenous Australians, and the adjustments themselves inherently introduce a degree of 
uncertainty around the YLL estimates produced. 
Future national data linkage studies would benefit from including a larger Indigenous 
sample size as well as cause of death information in order to overcome some of the 
limitations outlined above in adjustment factors produced. 
Adjustment factors used in this report 
Following extensive sensitivity analyses of Indigenous mortality data using the adjustment 
factors available from the ABS and AIHW studies described above, and after advice from the 
IRG and other experts, the agreed approach for the ABDS was to use mortality adjustment 
factors from the ABS 2011–12 CDE Study to adjust Indigenous deaths for YLL estimates and 
gap measures presented in the report, except for estimates by remoteness, for which 
adjustment factors from the AIHW EMD Study would be used.  
The ABS adjustment factors were chosen as they take into account under-identification in 
both mortality data and population data and therefore, in theory, provide consistency in the 
numerator and denominator used in Indigenous YLL calculations. Also, as noted earlier, the 
ABS adjustment factors are the official estimates of Indigenous mortality coverage in 
Australia. Further, sensitivity analyses undertaken by the AIHW examining the impact of 
using the different adjustment factors available (ABS compared to AIHW) showed that at the 
national level, the age patterns and disease rankings remained consistent using either set of 
adjustment factors. 
The ABS adjustment factors have been used to adjust Indigenous deaths for YLL estimates 
reported at the national level (comprising data from all states and territories), as well as  
sub-national estimates by state/territory for the four jurisdictions with the highest number of 
Indigenous deaths (New South Wales, Queensland, Western Australia and the Northern 
Territory only). Indigenous YLL estimates are not presented for Victoria, South Australia, 
Tasmania or the Australian Capital Territory due to the small number of Indigenous deaths 
reported for these jurisdictions each year and because individual state/territory adjustment 
factors are not available from the ABS for these states and territories.  
AIHW remoteness adjustment factors have been used to calculate YLL estimates by 
remoteness due to a number of limitations with the ABS remoteness adjustment factors 
outlined in the section above.  
For estimates by socioeconomic disadvantage, as no adjustment factors are available at this 
level, the ABS adjustment factors used to adjust Indigenous deaths at the national level 
(which include an age-adjustment) have been applied to each socioeconomic disadvantage 
quintile used. This assumes that there are no differences in Indigenous identification 
between the Indigenous persons living in each socioeconomic disadvantage quintile other 
than those resulting from age. However, differences in identification by remoteness and 
geographical area are also likely to impact on the YLL estimates by socioeconomic 
disadvantage quintile and this should be kept in mind when interpreting the estimates 
presented by socioeconomic disadvantage in this report. 
The mortality adjustment factors used to adjust Indigenous deaths in the calculation of YLL 
estimates presented in this report are provided in Table E.3. 
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Table E.3: Indigenous mortality adjustment factors used for YLL estimates in this report 
Level of reporting Disaggregation ABS CDE Study 
adjustment factor 
AIHW EMD Study 
adjustment factor 
National and SEIFA estimates 0–14 years 1.21  . . 
15–59 years 1.12  . . 
60 years and over 1.29  . . 
State/territory estimates NSW 1.42  . . 
Qld 1.24  . . 
WA 1.14  . . 
NT 0.96  . . 
Remoteness estimates Major cities . . 1.25 
Inner regional  . . 1.22 
Outer regional . . 1.12 
Remote . . 1.04 
Very remote . . 1.02 
Process of adjusting Indigenous deaths for under-identification for 
YLL calculations 
Adjusting for Indigenous under-identification in YLL calculations consists of three steps, 
described below.  
First, the number of Indigenous deaths recorded in the AIHW’s National Mortality Database 
for each age, sex and cause of death is multiplied by the relevant adjustment factor to obtain 
an adjusted number of Indigenous deaths. This reflects the expected, ‘real’ number of 
Indigenous deaths that occurred during the period of analysis.  
Second, adjusted Indigenous deaths for each age, sex and disease group are subtracted from 
the total number of deaths for the same age, sex and disease group, to obtain an adjusted 
number of non-Indigenous deaths. This step is based on the assumption that the relevant 
adjustment factor provides a sufficient level of adjustment; therefore the adjusted data will 
contain no deaths with a ‘not stated’ Indigenous status. It also ensures that the total number 
of deaths recorded in Australia remains the same following adjustment for Indigenous 
under-identification. The adjusted number of non-Indigenous deaths, together with the 
adjusted number of Indigenous deaths, is used in gap calculations (see Attachment F for 
details on methods used to calculate the YLL gap). 
Lastly, adjusted Indigenous death numbers for each age, sex and disease group are 
multiplied by the standard life expectancy and then summed to calculate the total YLL for 
the Indigenous population. The same step is undertaken for non-Indigenous deaths to 
calculate YLL for the non-Indigenous population for use in gap calculations. 
The adjustment factors were applied to all three years of Indigenous deaths included in the 
YLL estimates presented in this report (2009–2011). This assumes that the level of Indigenous 
identification in deaths data estimated for the period for which the ABS CDE Study (2011–12) 
and AIHW EMD Study (2008–2010) were undertaken applies to the reference year of 2010 
used for the burden of disease estimation. While this is a reasonable assumption given that 
the ABS and AIHW adjustment factors align closely to the reference period of this study, 
Indigenous identification can change slightly over time periods such as these in both 
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mortality data and in population data. For example, Indigenous identification in the Census 
was shown to increase quite substantially between the 2006 and 2011 Censuses, and 
Indigenous identification in mortality data is believed to have improved over time. 
However, this is expected to have a minimal impact on the estimates reported and on the 
interpretation of results presented in this report.  
The adjustment factors were also applied equally to all causes of death. This was because 
national adjustment factors by cause of death are not available from either the ABS or AIHW 
data linkage studies. Applying the adjustment factors equally to all causes of death assumes 
that there are no major differences in Indigenous identification by cause of death above what 
would be captured through applying age-specific adjustment factors (which should, in part, 
take account of differences in identification for diseases that are largely associated with age). 
While some states and territories have recently undertaken data linkage studies which have 
included cause-of-death information (WA Health unpublished; NSW Health 2012) and have 
suggested there may be some variance in Indigenous identification by cause of death, the 
levels and pattern of identification by cause of death were somewhat different between the 
studies. These studies also had a number of limitations, which led to a decision by the 
AIHW, in consultation with the IRG, not to use their results to generate additional 
adjustment factors by cause of death to be used for Indigenous YLL estimates for the ABDS.  
The discussion above highlights the need for national and/or state and territory data linkage 
studies to include an examination of Indigenous identification by cause of death using a 
consistent approach. This will enable disease-specific adjustments to be made in future 
burden of disease studies. 
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Appendix F: Measuring the gap 
Measuring the mortality ‘gap’ between Indigenous and non-Indigenous Australians is of key 
interest to current policymakers, as reflected in the COAG commitment to close the gap in 
Indigenous life expectancy within a generation (COAG 2009). This Appendix details the 
methods and metrics used to measure and report on the gap in fatal burden (YLL) between 
the Indigenous and non-Indigenous populations in this report. 
Age-standardisation 
As the risk of some conditions or injuries is strongly correlated with age, crude rates are not 
suitable for comparing rates of mortality or fatal burden (YLL) for different populations or 
groups. More meaningful comparisons can be made using age-standardised rates, with such 
rates adjusted for age in order to facilitate comparisons between populations that have 
different age structures, such as between Indigenous Australians and non-Indigenous 
Australians. This standardisation process effectively removes the influence of age structure 
on the overall summary rate. 
There are two main approaches to age-standardisation: direct age-standardisation and 
indirect age-standardisation. Both consist of taking a weighted average of the age-specific 
rates.  
In this report, direct age-standardisation has been used to calculate age-standardised YLL 
rates for the Indigenous and non-Indigenous populations. These were derived by 
multiplying the age-specific YLL rates observed in the population of interest (in this case the 
Indigenous and non-Indigenous populations) by the age-specific population numbers for the 
standard population (in this case, the Australian ERP as at 30 June 2001, based on the 2001 
Census). The next step was to sum across the age groups and divide this sum by the total of 
the standard population to give an age-standardised rate for the population of interest. 
Finally, this is expressed as a rate per 1,000 population. 
The direct age-standardisation method was used as it enables rates to be compared over time 
(needed for time series analyses), and can also be used for making multiple comparisons (for 
example, cause by sex or cause by state/territory). This is because directly age-standardised 
rates can be compared to each other as they are based on the same standard population. 
These comparisons are not possible using the indirect method of age-standardisation as 
indirectly age-standardised rates can only be compared to the standard, and not to each 
other. A disadvantage of the direct method, however, is that it can be sensitive to small 
numbers of cases. Consequently, calculating directly age-standardised rates for small 
populations where there can be large fluctuations in age-specific rates can result in adjusted 
rates that are less precise or stable than adjusted rates produced using the indirect method of 
age-standardisation.  
Gap (inequality) measures 
There are two measures available for comparing rates between two populations based on the 
direct age-standardisation method. These are the rate ratio and the rate difference, and are 
described below.  
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The rate ratio measures the relative difference between two population groups (for example, 
Indigenous and non-Indigenous Australians) and is calculated by dividing one age-
standardised rate by the other. Ratios greater than 1 indicate a higher rate of fatal burden in 
the population of interest (in this case, the Aboriginal and Torres Strait Islander population), 
while ratios less than 1 indicate a lower rate of fatal burden in the population of interest. 
The rate difference provides a measure of the absolute difference in age-standardised rates 
between two populations and is calculated by subtracting one from the other.  
In this report, both rate differences and rate ratios are provided as a means to more readily 
compare YLL rates for Indigenous and non-Indigenous people, as they both provide 
different information which is considered useful to examine mortality inequalities. For an 
explanation of how to interpret these statistics, see Box F.1.  
Box F.1: Interpreting rate differences and rate ratios 
Both rate differences and rate ratios measure the relationship between the rates of two 
populations, but they do it in different ways.  
Rate differences are calculated as ‘Rate 1’ minus ‘Rate 2’. This statistic measures the literal, 
or absolute, gap between populations without respect to their relative size. In this report, 
rate differences are shown as the Indigenous age-standardised YLL rate minus the non-
Indigenous age-standardised YLL rate, expressed per 1,000 population.  
The rate difference is also used in this report to calculate the proportion of the total gap in 
YLL that each disease group contributes (calculated by dividing the YLL rate difference for 
each respective disease group by the total rate difference for all causes of death). 
Rate ratios are calculated as ‘Rate 1’ divided by ‘Rate 2’. This statistic takes scale into 
account—a difference of 5 is more noteworthy if the comparative figure is 10 rather than 
1,000. In this report, rate ratios are shown as the Indigenous age-standardised YLL rate 
divided by the non-Indigenous age-standardised YLL rate.  
Rate ratios are often used to describe the degree of inequality. But, in some situations the 
ratio can be misinterpreted. A large rate ratio does not necessarily imply that an event has a 
large absolute impact. Events that are rare in one population can produce large rate ratios in 
the comparative population, irrespective of the level of prevalence or mortality. In addition, 
a decline in the rate ratio can sometimes be observed when rates of disease (and rate 
differences between two populations) are on the rise. 
Sensitivity analyses using different standardisation methods 
The AIHW undertook sensitivity analyses to examine the impact and robustness of using the 
direct method of age-standardisation (especially when applied to rates based on small 
numbers of deaths) by comparing these results to results using the indirect method of  
age-standardisation.  
These analyses showed that both methods of age-standardisation produced similar results 
for the overall gap, as measured by the rate ratio, and the disease groups with the highest 
rate ratios. The indirect method, however, produced slightly higher rate ratios in most cases. 
For example, the direct method of age-standardisation resulted in a total YLL rate ratio of 2.6 
compared to 2.8 using the indirect method. Endocrine disorders and Kidney and urinary diseases 
were the two conditions with the largest rate ratios derived from both direct and indirect 
age-standardisation, although the order switched depending on which method was used— 
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Kidney and urinary diseases was slightly higher based on the indirect method, while Endocrine 
disorders was slightly higher based on direct age-standardisation. 
Both methods of age-standardisation also produced somewhat similar results for the leading 
contributors to the gap by disease group, as measured by the percentage contribution of each 
disease to the total gap. For example, Cardiovascular diseases was the largest contributor to the 
gap in the fatal burden between Indigenous and non-Indigenous Australians using both the 
direct and indirect methods of age-standardisation (representing 26.5% and 24.3% of the gap 
respectively). Injuries and Cancer and other neoplasms were both also among the top three 
leading causes of fatal burden using the two methods of age-standardisation. However, 
Cancer and other neoplasms was ranked second using the direct method and Injuries was 
ranked second using the indirect method.  
Although rankings were similar using the two methods of standardisation, there were some 
notable differences in the relative contributions of selected causes to the gap, such as for 
Injuries (contributing to 13% of the gap using direct age-standardisation compared to 21% 
using indirect age-standardisation); Cancer and other neoplasms (15% compared to 11%), 
Endocrine disorders (11% compared to 8%) and Infant and congenital conditions (3% compared 
to 8%).  
These differences are likely to be due to differing age-profiles for these diseases and the 
concentration of most deaths in certain age groups only—for example, deaths from injuries 
are largely concentrated in the young and middle age groups, while deaths from infant and 
congenital conditions are concentrated almost entirely in the infant and 1–4 year age groups. 
As mentioned earlier, the direct age-standardisation method is more sensitive than the 
indirect method to having a small number of deaths (or no deaths) in some age groups. 
However, as also discussed earlier in this Appendix, the direct method of standardisation 
has been used for estimates presented in this report as it enables multiple comparisons (such 
as state/territory by sex, which is important for sub-national estimates) as well as 
comparisons over time (which will become important for future updates to Indigenous 
burden of disease estimates and for backcasting or revising estimates for earlier years. 
 98 Fatal burden of disease in Aboriginal and Torres Strait Islander people 2010 
Glossary 
Aboriginal and/or Torres Strait Islander: A person of Aboriginal and/or Torres Strait 
Islander descent who identifies as an Aboriginal and/or Torres Strait Islander. See also 
Indigenous. 
Age weighting: A method used to adjust the relative value of years lived at different ages, 
for example, to value a year lived by a young adult more highly than a year lived at older 
ages. Age weighting means that events in some age groups will have greater influence on the 
results than others. 
Associated cause(s) of death: All causes listed on the death certificate, other than the 
underlying cause of death.  
Attributable burden: The burden attributed to a particular risk factor. It is the reduction in 
burden that would have occurred if exposure to the risk factor had been avoided.  
Burden of disease and injury: Term referring to the quantified impact of a disease or injury 
on an individual or population, using the disability-adjusted life year (DALY) measure. 
Cause list: The cause list details the specific diseases and causes of injury for which the 
estimates of the number of deaths, YLL, YLD and DALYs will be made. 
Cause of death: The causes of death entered on the Medical Certificate of Cause of Death are 
all diseases, morbid conditions or injuries that either resulted in or contributed to death, and 
the circumstances of the accident or death. See also underlying cause(s) of death and 
associated cause(s) of death. 
Closing the gap: A commitment made by Australian governments in 2008 to improve the 
lives of Aboriginal and Torres Strait Islander Australians. See also Gap. 
Condition (health condition): A broad term that can be applied to any health problem, 
including symptoms, disease, and certain risk factors, such as high blood cholesterol and 
obesity. Often used synonymously with disorder or problem. 
Data linkage (also referred to as data integration or record linkage): The bringing together 
(linking) of information from two or more different data sources that are believed to relate to 
the same entity, for example, the same individual or the same institution. 
Disability: In burden of disease analysis, any departure from an ideal health state. 
Disability-adjusted life year (DALY): A year of healthy life lost, either through premature 
death or equivalently through living with disability due to illness or injury. It is the basic 
unit used in burden of disease and injury analysis. 
Disability weight: A factor that reflects the severity of health loss from a particular health 
state on a scale from 0 (perfect health) to 1 (equivalent to death). 
Discounting: A method used to adjust the relative value of years lived (or lost) in the future. 
It is based on the assumption that a year lived in the future is of less ‘value’ than a year lived 
now. ‘Discounting for future benefits’ is standard practice in economic analysis. 
Disease group: Broader groupings of the specific diseases and causes of injury detailed in 
the cause list. 
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Estimated resident population (ERP): The official Australian Bureau of Statistics estimate of 
the Australian population. The ERP is derived from the 5-yearly Census counts, and is 
updated quarterly between censuses. It is based on the usual residence of the person. Rates 
are calculated per 1,000 or 100,000 mid-year (30 June) ERP. 
Fatal burden: Burden of disease caused by mortality. Represented by the years of life lost 
measure.  
Gap: The difference between Indigenous rates and non-Indigenous rates for a particular 
health measure. 
Health states: Groups of sequelae reflecting key differences in symptoms and functioning. 
Incidence: The number of new cases (of an illness or event, and so on) occurring during a 
given period. 
Indigenous: A person of Aboriginal and/or Torres Strait Islander descent who identifies as 
an Aboriginal and/or Torres Strait Islander. See also Aboriginal or Torres Strait Islander. 
Life expectancy: How many years a person can expect to live, on average, given prevailing 
mortality rates.  
Life table: A table that shows, for each age, the probability that a person of that age will die 
before their next birthday. 
Mortality: Death. 
Mortality gap: The difference between age-standardised YLL rates for the Indigenous and 
non-Indigenous populations. 
Multiple causes of death: All causes listed on the death certificate. This includes the 
underlying cause of death and the associated cause(s) of death. See also cause of death. 
Non-fatal burden: Burden of disease caused by morbidity (ill health). Represented by the 
years lived with disability measure. 
Prevalence: The number (of cases, instances) in a population at a given time. 
Redistribution causes: Causes of death that require allocation to other causes because the 
original underlying cause of death does not suit burden of disease analysis. 
Risk factor: Any factor which represents a greater risk of a health disorder or other 
unwanted condition or event. Some risk factors are regarded as causes of disease, others are 
not necessarily so. Along with their opposites, protective factors, risk factors are known as 
determinants. 
Sequelae: Consequences of diseases and injuries. 
Under-identification: This arises when a person’s Indigenous status is not collected or 
accurately recorded. 
Underlying cause of death: The disease or injury that initiated the chain of events leading 
directly to death, or the circumstances of the accident or violence that produced the fatal 
injury.  
Years of life lost (YLL): Years of life lost due to premature mortality, calculated as the 
difference between the age at death and the standard life expectancy at that age. 
Years lived with disability (YLD): A measure of non-fatal disease burden, weighted for the 
severity of the condition. 
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